ketoconazole has been researched along with amphotericin b in 604 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 237 (39.24) | 18.7374 |
1990's | 189 (31.29) | 18.2507 |
2000's | 107 (17.72) | 29.6817 |
2010's | 62 (10.26) | 24.3611 |
2020's | 9 (1.49) | 2.80 |
Authors | Studies |
---|---|
Bizzarri, B; Carradori, S; D'Ascenzio, M; De Monte, C; Grande, R; Mari, E; Patsilinakos, A; Ragno, R; Rivanera, D; Sabatino, M; Secci, D; Zicari, A | 1 |
Chou, S; Dou, X; Shan, A; Song, J; Wang, J; Wang, Z; Yang, Y; Yang, Z | 1 |
Wang, SQ; Wang, YF; Xu, Z | 1 |
Asif, M; Husain, A; Iqbal, MA; Iram, F; Khan, SA | 1 |
Braga, SS | 1 |
Jaisingh, A; Maurya, IK; Salunke, DB; Singh, R | 1 |
Andrade, JT; Antunes Fernandes, SO; Araújo, LA; Cardoso, VN; Johann, S; Lima, WG; Morais, FB; Prates Silva, MK; Ribeiro Viana, GH; Saldanha, AA; Siqueira Ferreira, JM; Soares, AC; Sousa, JF | 1 |
Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
Adams, JL; Ator, MA; Barone, JM; Dolle, RE; Frey, CL; Kruse, LI; Schmidt, SJ | 1 |
Enriz, R; Gonzalez Sierra, M; Orellana, G; Pezzenati, G; Rodríguez, G; Zacchino, S | 1 |
Abdel-Kader, MS; Bahler, BD; Bursuker, I; Kingston, DG; Malone, S; Mamber, SW; Neddermann, KM; van Troon, F; Werkhoven, MC; Wisse, JH | 1 |
Buarque De Gusmao, N; Guiraud, P; Seigle-Murandi, F; Steiman, R | 1 |
Enriz, RD; Furlán, RL; Giannini, FA; López, SN; Muñoz, L; Pezzenati, GD; Rodríguez, AM; Santecchia, CB; Zacchino, SA | 1 |
Agarwal, N; Raghuwanshi, SK; Ram, VJ; Shukla, PK; Upadhyay, DN | 1 |
Buchta, V; Fáková, H; Koudelka, P; Kubanová, P; Pour, M; Pourová, H; Schiller, R; Spulák, M; Voprsalová, M; Wsól, V | 1 |
Avery, T; Greatrex, B; Macreadie, I; Macreadie, P; Taylor, D | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abonía, R; Delgado, P; Enriz, RD; Garibotto, FM; Insuasty, B; Juárez, S; Nogueras, M; Quiroga, J; Rodero, L; Sortino, M; Zacchino, SA | 1 |
Avery, TD; Greatrex, BW; Macreadie, IG; Macreadie, PI; Robinson, TV; Taylor, DK | 1 |
Bergès, T; Bouchara, JP; Chabasse, D; Hennequin, C; Tronchin, G; Vandeputte, P | 1 |
Cheng, S; Clancy, CJ; Clapp, W; Nguyen, KT; Nguyen, MH | 1 |
Cao, YB; Jiang, YY; Sun, QY; Wu, QY; Xu, JM; Zhang, DZ; Zhang, J; Zhang, WN; Zhao, HQ | 1 |
Kang, TH; Kim, S; Park, JS; Suh, YG; Yu, KA | 1 |
Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Chaffin, WL; Mekala, S; Perumal, P | 1 |
Deising, HB; Serfling, A; Wohlrab, J | 1 |
Calderone, R; Chauhan, N; Kruppa, M | 1 |
Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
Cechinel Filho, V; Corrêa, R; Sortino, M; Zacchino, S | 1 |
Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Gutierrez, MO; Rodriguez-Tudela, JL | 1 |
Azor, M; Cano, J; Fothergill, AW; Gené, J; Guarro, J; Rinaldi, MG; Sutton, DA | 1 |
Enriz, RD; Kortvelyesi, T; Luiten, PG; Masman, MF; Penke, B; Raimondi, M; Rodríguez, AM; Somlai, C; Zacchino, SA | 1 |
Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP | 1 |
Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
Jin, LJ; Samaranayake, LP; Samaranayake, YH; Seneviratne, CJ | 1 |
Bergès, T; Bouchara, JP; Chabasse, D; Ernoult, E; Larcher, G; Tronchin, G; Vandeputte, P | 1 |
Alvarez, SL; Kouznetsov, VV; Meléndez Gómez, CM; Sortino, MA; Zacchino, SA | 1 |
Escalante, A; Gattuso, M; Pérez, P; Zacchino, S | 1 |
Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
Aher, NG; Bhat, MK; Kumar, A; Mishra, NN; Pore, VS; Sharma, A; Shukla, PK | 1 |
Rahkhoodaee, F; Raymond, M; Tsao, S | 1 |
Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
Derita, M; Leal, PC; Mascarello, A; Nunes, RJ; Yunes, RA; Zacchino, S; Zuljan, F | 1 |
Bergès, T; Bouchara, JP; Chabasse, D; Renier, G; Rocher, F; Tronchin, G; Vandeputte, P | 1 |
Alvarez, G; Benítez, D; Boiani, L; Cerecetto, H; Gerpe, A; González, M; Hernández, P; Quiroga, M; Sortino, M; Zacchino, S | 1 |
Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
Enriz, RD; Garibotto, FM; Garro, AD; Luiten, PG; Masman, MF; Penke, B; Raimondi, M; Rodríguez, AM; Somlai, C; Zacchino, SA | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Boiani, L; Cerecetto, H; Gerpe, A; González, M; Hernández, P; Sortino, M; Zacchino, S | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Warrilow, AG; Weig, M | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Enriz, RD; Farkas, V; Olivella, MS; Penke, B; Perczel, A; Rodríguez, AM; Somlai, C; Zacchino, SA | 1 |
Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
Bader, O; Gross, U; Kelly, DE; Kelly, SL; Martel, CM; Parker, JE; Rolley, N; Warrilow, AG; Weig, M | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Enriz, RD; Garibotto, FM; Garro, AD; Penke, B; Perczel, A; Raimondi, M; Rodríguez, AM; Somlai, C; Zacchino, SA | 1 |
Carvalho, L; Castanys, S; Gamarro, F; Manzano, JI; Pérez-Victoria, JM | 1 |
Cao, Y; Chai, X; Jiang, Y; Sun, Q; Wu, Q; Xu, J; Yu, S; Zhang, D; Zhang, J; Zou, Y | 1 |
Cechinel Filho, V; Enriz, R; Garibotto, F; Gupta, M; Sortino, M; Zacchino, S | 1 |
Chai, X; Hu, H; Liao, J; Wu, Q; Xu, M; Yu, S; Zhao, Q; Zou, Y | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Cobo, J; Enriz, RD; Giannini, F; Marchal, A; Melguizo, M; Nogueras, M; Olivella, M; Raimondi, M; Sánchez, A; Zacchino, S | 1 |
del Olmo, E; Derita, MG; Kouznetsov, VV; Meléndez Gómez, CM; Svetaz, L; Zacchino, SA | 1 |
Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
Bowlin, TL; Ding, X; Kwasny, SM; Nguyen, ST; Opperman, TJ; Peet, NP; Williams, JD | 1 |
Akdemir, A; Bizzarri, B; Bolasco, A; Caprara, F; Carradori, S; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zicari, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aktumsek, A; Bizzarri, B; Carradori, S; Chimenti, P; De Monte, C; Mari, E; Mollica, A; Rivanera, D; Secci, D; Zengin, G; Zicari, A | 1 |
Chen, F; Chen, W; Lan, L; Li, B; Li, J; Liu, Y; Mao, F; Ni, S; Wei, H; Zhu, J | 1 |
Denning, DW; Hanson, LH; Perlman, AM; Stevens, DA | 1 |
de Gans, J; Eeftinck Schattenkerk, JK; Portegies, P; Stam, J; Tiessens, G; van Boxtel, CJ; van Ketel, RJ | 1 |
Bradsher, RW | 3 |
Wheat, LJ | 2 |
Chiewchanvit, S; Hirunsri, P; Nelson, KE; Sirisanthana, T; Supparatpinyo, K; Uthammachai, C | 1 |
Andrade, J; Armstrong, D; Edwards, F; Niki, Y; Schmitt, HJ | 1 |
Gallin, JI; Kwon-Chung, KJ; Williamson, PR | 1 |
Cajot, MA; Gosselin, B; Goullard, L; Koussa, A; Marquette, F; Pol, A; Roux, JP; Soots, G; Warembourg, H | 1 |
van't Wout, JW | 1 |
Van Cutsem, J | 1 |
Carbon, C; Eloy, O; Ghnassia, JC; Joly, V; Yeni, P | 1 |
Atkinson, K; Enno, A; Walsh, M; White, L | 1 |
Lesher, JL | 1 |
Bava, AJ; Negroni, R | 1 |
Büchner, T; Roos, N | 1 |
Lode, H; Schaberg, T | 1 |
al-Abedeen Jamjoom, Z; al-Hedaithy, S; Jamali, A; Jamjoom, A; Malabarey, T | 1 |
Collignon, P; McGregor, A; McNicol, D | 1 |
Lozano, MC; Martín, E; Parras, P | 1 |
Chotmongkol, V; Sookprasert, A | 1 |
Kujala, P; Ruutu, P | 1 |
Navarro, EE; Romero, RC; Tuazon, CU; Tupasi, TE; Verallo, VM | 1 |
Matsuda, T; Matsumoto, T | 1 |
Hoffman, KD; Madigan, JE; Mansmann, RA; Pappagianis, D; Ziemer, EL | 1 |
Hernández Molina, JM; Llosá, J; Martinez Brocal, A; Ventosa, A | 1 |
Kurata, H; Matsuoka, H; Oh, K; Sumita, O; Takatori, K | 1 |
Acker, JD; Brint, JM; Farr, RC; Gardner, G; Haglund, LF; Land, M; Schweitzer, JB; West, BC | 1 |
Grillo, HC; Mathisen, DJ | 1 |
Zijlstra, EE | 1 |
Lelarge, P; Mariot, J | 1 |
Annuar, NM; Ghazali, AK; Kassim, F; Lim, CS; Murad, Z; Zainudin, BM | 1 |
de Montclos, H; de Montclos, M; Flandrois, JP | 1 |
Alfonso, E; Maskin, SL | 1 |
Cavanna, C; Michelone, G; Tinelli, M | 1 |
Burton, DM; Kearns, DB; Pransky, SM; Seid, AB | 1 |
Aoki, K; Matsuzaka, A; Uchida, K; Yamaguchi, H | 1 |
Aoki, K; Hosaka, J; Uchida, K; Yamaguchi, H | 1 |
Cobbs, CG; Dismukes, WE; Lank, KM; Smith, KR | 1 |
Chakrabarti, A; Kaur, I; Kumar, B; Sharma, VK | 1 |
de Pauw, BE; Fibbe, WE; Novakova, I; van der Meer, JW; van't Wout, JW; Verhagen, CA | 2 |
Gerarden, T; Hollis, R; Isenberg, HD; Levenson, D; Pfaller, MA; Smith, MA; Tucci, CB | 1 |
Bolard, J; Carbon, C; Joly, V; Saint-Julien, L; Saint-Pierre-Chazalet, M; Yeni, P | 1 |
Carrasco, R; Cervelló, A; Navarro, V; Nieto, A; Roig, P; Salavert, M | 1 |
Barton, JH; Burbach, JW; Coggin, JT; Fox, RL; Juarbe, HM; Julie, NL; Koss, G; Ligon, CH; Mayo, FJ; Sauri, MA | 1 |
Hamory, BH; Joshi, N | 1 |
Bianchi Porro, G; Cernuschi, M; Lazzarin, A; Parente, F; Rizzardini, G; Valsecchi, L | 1 |
Aricò, M; Burgio, GR; Caselli, D; Cavanna, C; Michelone, G; Nespoli, L | 1 |
Graybill, JR; Sharkey, PK | 1 |
Shindo, K | 1 |
Fraimow, HS; Moore, JH; Ost, D; Paluzzi, RG; Sachs, MK | 1 |
Chafey, S; Franker, C; Hardy, WD; Lucatorto, FM | 1 |
Li, YP; Weingardt, J | 1 |
Browne, M; Cotton, D; Gress, J; Hathorn, J; Marshall, D; McKnight, J; Rubin, M; Skelton, J; Thaler, M; Walsh, TJ | 1 |
Dettori, G; Manzara, S; Morace, G | 1 |
Benhamou, E; Hartmann, O; Lemerle, J; Maraninchi, D; Noguès, C; Valteau, D | 1 |
Feman, SS; Johns, K; Pritchett, P; Salmon, WD; Westrich, DJ | 1 |
Bercy, P; De Beule, F; Ferrant, A | 1 |
Ritchie, DJ | 1 |
Barriere, SL | 1 |
Chatterjee, PK; Sharma, S; Singh, SM | 1 |
Ampel, NM; Clark, RJ; Dols, CL; Edwards, JE; Fish, DG; Galgiani, JN; Johnson, CH; Kelly, PC; Pappagianis, D; Wasserman, RB | 1 |
Hay, RJ; Mehentee, JF | 1 |
Raven, EJ; van 't Wout, JW; van der Meer, JW | 1 |
Hector, RF; Yee, E | 1 |
Andreassian, B; Bouttier, S; Branger, C; Elzaabi, M; Icard, P; Nussaume, O | 1 |
Linde, I; Mattie, H; Meynaar, I; Poell, R; Van 't Wout, JW; Van Furth, R | 1 |
Easty, DL; Hart, JC; Ragge, NK; Tyers, AG | 1 |
Denning, DW; Hanson, LH; Stevens, DA | 1 |
Meunier, F | 1 |
Pechère, JC; Ponce, E | 1 |
Brod, RD; Clarkson, JG; Culbertson, WW; Flynn, HW; Miller, D; Pflugfelder, SC | 1 |
Sarosi, GA | 1 |
Akagawa, Y; Minagi, S; Miyake, Y; Suginaka, H; Tsunoda, T; Tsuru, H | 1 |
Cook, RA; Galgiani, JN; McIntyre, KA | 1 |
Bartlett, MS; Body, BA; Espinel-Ingroff, A; Fromtling, RA; Galgiani, JN; Hall, GS; Hughes, CE; Odds, FC; Pfaller, MA; Rinaldi, MG | 1 |
Herrod, HG | 1 |
Burns, DK; Hernandez, JA; Nightingale, SD; Parks, JM; Pounders, SM; Reynolds, J | 1 |
Bush, DC; Dennehy, JJ; Moyer, RA | 1 |
Black, GB; MacDonald, PB; MacKenzie, R | 1 |
Lucente, FE; Meiteles, LZ | 1 |
Hiltbrand, JB; McGuirt, WF | 1 |
Bartholomew, C; Barton, EN; Basdayemaharaj, K; Cleghorn, F; Ince, WE; Jankey, N; Patrick, AL; Roberts, L; Suite, M | 1 |
Bronnimann, DA; Galgiani, JN | 1 |
Davies, SF; Sarosi, GA | 1 |
Antoine, GA; Raterink, MH | 1 |
Almaviva, M; Cristina, S; De Maria, R; Ferrazzi, P; Fiocchi, R; Langer, M; Negri, C; Scoccia, S; Tortorano, AM; Viviani, MA | 1 |
Mattie, H; van Furth, R; Van t Wout, JW | 1 |
Bava, AJ; Finquelievich, JL; Iovannitti, C; Negroni, R | 2 |
Burke, J; Johnson, EM; Pracharktam, R; Warnock, DW | 1 |
Fransen, J; Janssen, PA; Van Cutsem, J; Van Gerven, F | 1 |
Cavanna, C; Gramegna, G; Lombardi, G; Marangoni, E; Michelone, G; Poma, G | 1 |
Dupont, B | 2 |
Baker, JH; Goodpasture, HC; Kuhns, HR; Rinaldi, MG | 1 |
Martin, RA; Montalto, N; Williams, T | 1 |
Cárdenas Martínez, A; Giménez-Esparza, JA; Gómez Trujillo, FM; Juárez Fernández, C | 1 |
Evans, WK; Stewart, DJ | 1 |
Pallister, CJ; Warnock, DW | 1 |
Radentz, WH | 1 |
Hobbs, ER | 1 |
Steck, WD | 1 |
Ray, TL | 1 |
Chuck, SL; Sande, MA | 1 |
Bille, J; Calandra, T; de Muralt, B; Glauser, MP; Zanetti, G | 1 |
Hamill, RJ; Johnson, PC; Sarosi, GA | 1 |
Polak, A | 2 |
Longman, LP; Martin, MV | 1 |
Walsh, TJ | 1 |
Pizzo, A; Walsh, TJ | 1 |
Cohen, O; De Pauw, BE; De Vries, F; De Witte, T; Donnelly, JP; Schattenberg, A | 1 |
Bennett, JE; Kan, VL | 1 |
Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA | 1 |
Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
Ahrens, J; Graybill, JR | 1 |
Kessler, HA; Pottage, JC | 1 |
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
Berman, JD; Gallalee, JV | 1 |
Andrews, RJ; Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
Ahrens, J; Graybill, JR; Sun, SH | 1 |
Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
Meingassner, JG; Schaude, M | 1 |
Douglas, CJ; Johnson, EM; Richardson, MD; Warnock, DW | 1 |
Graybill, JR; Palou de Fernandez, E; Patino, MM; Tarbit, MH | 1 |
Borgers, M; Cauwenbergh, G; Vanden Bossche, H | 1 |
Dixon, DM; Polak, A | 1 |
Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF | 1 |
Eleazer, GP | 1 |
Graybill, JR | 4 |
Galgiani, JN; Knoper, SR | 1 |
Iida, Y; Maehara, K; Mase, K; Okamoto, Y; Simojo, M; Takeuchi, J; Uwamori, H; Yasunaga, K; Yonezu, S | 1 |
Davies, SP; Denning, DW; Murray, WK; Patou, G; Webb, WJ | 1 |
Dennis, M; Le, CT | 1 |
Andrade, J; Armstrong, D; Bernard, EM; Edwards, F; Schmitt, B; Schmitt, HJ | 1 |
Cavanna, C; Garavelli, PL; Maccabruni, A; Michelone, G | 1 |
Carpenter, JT; Jones, MR; Rodu, B | 1 |
Kogawa, T; Kondo, M; Morita, Y; Naito, Y; Oyamada, H; Sugino, S; Tainaka, K; Yoshikawa, T | 1 |
McLeod, DG; Moul, JW; Peppas, DS | 1 |
Kalter, DC; McBride, ME; Wolf, JE | 1 |
Cloud, G; Craven, PC; Dismukes, WE; Galgiani, JN; Graybill, JR; Gregg, C; Huppert, M; Stevens, DA; Sugar, AM | 1 |
Gerarden, T; Pfaller, MA; Wenzel, RP; Yu, M | 1 |
Apperloo, AJ; Nelis, GF | 1 |
Bottone, EJ; Cronin, DC; Poon, M; Wormser, GP | 1 |
Buffard, Y; Gabriel, B; Goudard, M; Regli, P | 1 |
Dismukes, WE; Saag, MS | 1 |
Bodey, GP | 2 |
Caya, JG; Farmer, SG; Franson, TR; Kies, JC; Komorowski, RA; Williams, GA | 1 |
Kauffman, CA; Terpenning, MS | 1 |
Bull, R; Campbell, CK; Haines, ME; Mackenzie, DW; Millard, PR; Mitchell, RG; Peto, TE | 1 |
Evans, SG; Herman, MH; Kuntze, JR | 1 |
Davis, CP; Gudewicz, TM; Mader, JT | 1 |
Chikamori, T; Nagano, H; Saiki, S; Yamashina, A | 1 |
Cabrita, J; Cachão, P; Rocha, MM; Rodrigo, JG | 1 |
Britton, H; Dunn, JH; Shehab, ZM | 1 |
Bartkowski, DP; Lanesky, JR | 1 |
Cammarata, E; Dainelli, B; Falcioni, E; Mignini, F; Oliveri, S; Prenna, M; Ripa, S | 1 |
Couch, L; Mader, JT; Theilen, F | 1 |
Bacher, J; O'Leary, T; Pizzo, PA; Thaler, M | 1 |
Butt, F; Johnson, PC; Khardori, N; Mansell, PW; Najjar, AF; Sarosi, GA | 1 |
Badillet, G; De Roquancourt, A; Decazes, JM; Minozzi, C; Modai, J; Vittecoq, D | 1 |
Hay, RJ | 1 |
Feld, R; Haron, E; Hasselback, R; Matlow, A; Patterson, B; Tuffnell, P | 1 |
Garbrecht, M; Gressler, V; Hossfeld, DK; Müllerleile, U; von Paleske, A | 1 |
Goodman, DF; Stern, WH | 1 |
Head, WS; O'Day, DM; Robinson, RD | 1 |
Barrie, T | 1 |
Anderson, RW; Pruett, TL; Rotstein, OD; Simmons, RL | 1 |
Opal, SM; Pluss, JL | 1 |
Meyer, RD | 1 |
Brenciaglia, MI; Cipriani, P; Ghezzi, MC; Mancini, C; Trancassini, M | 1 |
Cauwenbergh, G | 1 |
Dunstan, RW; Langham, RF; Reimann, KA | 1 |
Chapin, K; Doern, GV; Rinaldi, MG; Tubert, TA | 1 |
Bodey, GP; Elting, L; Fainstein, V; Keating, M; Maksymiuk, A; McCredie, KB | 1 |
Krasne, DL; Lombard, CM; Tazelaar, HD | 1 |
Barrett, FF; Flynn, PM; Herrod, HG | 1 |
Abu Aisha, H; Chagla, AH; Laajam, M; Yaqoub, B | 1 |
Chan, FL; Huang, CY; Kwong, YL; Lam, KS; Woo, E; Yu, YL | 1 |
Brass, C; Espinel-Ingroff, A; Galgiani, JN; Gordon, MA; Kerkering, TM; Reiser, J | 1 |
Bevier, D; Panciera, DL | 1 |
Mihatsch, MJ; Müller, AM; Ryffel, B | 1 |
Dunlap, MD; Goodpasture, HC | 1 |
Liles, WJ; Moreno, AJ; Parker, AL; Sippo, WC; Weisman, IM | 1 |
Ceuppens, AM; Heymans, C; Meunier, F; Van der Auwera, P | 1 |
Guthrie, W; Haining, WM; O'Keefe, M; Young, JD | 1 |
Chambers, DK; Downie, RJ; Roberts, C; Rothburn, MM | 1 |
Ito, A | 1 |
Kurup, VP; Resnick, A; Rose, HD | 1 |
Bried, JM; Galgiani, JN | 1 |
Radetsky, M; Roe, MH; Todd, JK; Wheeler, RC | 1 |
De Villiers, PC; Smith, HE; Vismer, H | 1 |
Goldberg, DM; Mandell, W; Neu, HC | 1 |
Adam, RD; Bloom, JW; Bronnimann, DA; Galgiani, JN; Habib, MP; Petersen, EA; Porter, B | 1 |
Bremard, C; Fischer, A; Griscelli, C; Huu Trong, P; Mouy, R; Vilmer, E | 1 |
De Bernardis, F; Lorenzini, R; Mercantini, R | 1 |
Hammerschlag, MR; Rao, SP; Walk, JA | 1 |
Slama, TG; Wheat, LJ; Zeckel, ML | 1 |
Barrie, T; Davey, C; Dutton, GN; Ong-Tone, L; Servant, JB | 1 |
Quinn, DM | 1 |
Drouhet, E; Dupont, B | 1 |
Goetz, MB; Jones, JM | 1 |
Roudebush, P | 1 |
Abbott, AB; Cheesman, SL; Odds, FC | 1 |
Parkin, JL | 1 |
Abdo-Bassol, F; Aldana-Valenzuela, C; Manjarrez-Gutiérrez, G; Rodríguez-Cámara, A; Vargas-Origel, A | 1 |
Moriello, KA | 1 |
Lenhard, A | 1 |
Brummer, E; Hoyos, GL; Lefler, E; McEwen, JG; Restrepo, A; Stevens, DA | 1 |
Fisher, JF; Henson, DM | 1 |
Cavariani, MR; Dillon, NL; Franco, MF; Grizzo, W; Habermann, MC; Lastoria, JC; Marcondes, J; Marques, SA; Silva, NC; Stolf, HO | 1 |
Freeman, JM; Head, WS; O'Day, DM; Robinson, RD; Stern, WH | 1 |
Chandler, FW; Desai, D; Moore, FM; Schmidt, GM | 1 |
Frick, PG; Schaffner, A | 1 |
Peacock, JE; Wilson, G | 1 |
Brummer, E; Lefler, E; Perlman, AM; Stevens, DA | 1 |
Benowitz, BA; Jacobson, JA; Larsen, RA; Morris, AH | 1 |
Ahmad, S; Gallagher, N; Johnson, RJ; Ramsey, PG | 1 |
Head, WS; O'Day, DM; Ray, WA; Robinson, R | 2 |
Baudraz-Rosselet, F; Calandra, T; Francioli, P; Glauser, MP; Grigoriu, D; Ruffieux, C | 1 |
Barnert, J; Behr, W; Reich, H | 1 |
Bodet, CA; Drutz, DJ; Jorgensen, JH | 1 |
Ajello, L; Padhye, AA; Shlaes, DM; Vartian, CV | 1 |
Barnes, WG; Brabender, W; Hodges, GR; Ketcherside, J; Rengachary, S | 1 |
Flegel, H; Kaben, U; Uhlmann, H; Westphal, HJ | 1 |
Tan, CB; Tjia, TL; Yeow, YK | 1 |
Blue, JL; Greene, CE; Miller, DM | 1 |
Haneke, E | 1 |
Ho, NK | 1 |
Katzenstein, D | 1 |
Irvine, AR; Jacobs, RA; O'Day, DM; Pons, VG; Stern, WH; Stone, RD; Tamura, E | 1 |
Looker, DN | 1 |
Barkve, H; Langberg, CW; Tjørstad, K | 1 |
El-On, J; Weinrauch, L | 1 |
Durack, DT; Smego, RA | 1 |
Miller-Catchpole, R; Rippon, JW | 1 |
Gross, M | 1 |
Hughes, WT | 1 |
Kostiala, AA; Kostiala, I | 1 |
Bodey, GP; Fainstein, V; Hopfer, R; Luna, M; Maksymiuk, AW; Thongprasert, S | 1 |
Gordon, MA; Henderson, RW; Lapa, EW; Weitzman, I | 1 |
Lefrock, JL; Smith, BR | 1 |
Barker, P; Lauver, MA | 1 |
Diebold, MD; Eschard, JP; Gari, M; Janody, D; Leutenegger, M; Poynard, JP; Ricard, Y | 1 |
Fernández, M; García, JJ; Idoria, CA; Jacob, E | 1 |
Blacklock, HA; Boesen, E; Corringham, R; Fox, J; Gascoigne, E; Hann, IM; Hoffbrand, AV; Keaney, M; Noone, P; Prentice, HG; Shannon, M; Szawatkowski, M | 1 |
Catovsky, D; Darrell, JH; Donnelly, JP; Galton, DA; Goldman, JM; Starke, ID | 1 |
Evans, M; Pollock, AV | 1 |
Anagnostopoulos, C; Lerner, SA; Resnekov, L; Samelson, LE | 1 |
Foster, CS; Giovanoni, R; Lass, JH; Moran-Wallace, K | 1 |
Högl, F; Raab, W | 1 |
Jones, DB | 1 |
Alexander, GA; Drutz, DJ; Graybill, JR; Jorgensen, JH | 1 |
Krogstad, DJ; Pfaller, MA | 1 |
Broberg, PH; Gentry, LO; Green, MT; Jones, DB; Osato, MS | 1 |
Berman, JD | 1 |
Fields, BT; France, GL; Marmer, DJ; Steele, RW | 1 |
Chmel, H; Corrado, M; Eng, RH; Mangura, C; Person, A | 1 |
Alford, RH; Bradsher, RW; Hawkins, SS; Spickard, WA | 1 |
Roberts, DT | 1 |
Chretien, JH; Garagusi, VF | 1 |
Jones, HE | 1 |
Brajtburg, J; Kobayashi, D; Kobayashi, GS; Medoff, G | 1 |
Durack, DT; Perfect, JR | 1 |
Harris, LF; Le Grand, MP; Serio, RA | 1 |
Corrado, ML; Cummings, M; Eng, RH; Kramer, M | 1 |
Höffken, G; Lode, H | 1 |
Hironaga, M; Mochizuki, T; Watanabe, S | 1 |
Alford, RH; Dean, RH; Hawkins, SS; Miller, BM; Smith, BM; Waterhouse, G | 1 |
Meunier-Carpentier, F | 3 |
Odds, FC | 1 |
Bastide, JM; Bastide, M; Jouvert, S | 1 |
Craven, PC; Dismukes, WE; Graybill, JR; Jorgensen, JH; Levine, BE | 1 |
Polak, A; Scholer, HJ; Wall, M | 1 |
Craven, PC; Graybill, JR | 2 |
Brodaty, D; Chapman, A; Drouhet, E; Guilmet, D; Kouvalchouk, JF; Laudet, J; Ziza, JM | 1 |
Crowley, JJ; McGuffin, RW; Meeker, TC; Shiota, FM; Siegel, MS | 1 |
Feingold, DS; Sud, IJ | 1 |
Arant, BS; Hogg, RJ; Houser, MT | 1 |
Brabender, W; Hodges, GR | 1 |
Drutz, DJ | 1 |
Dismukes, WE; Stamm, AM | 1 |
Franti, CE; Hoeprich, PD; Huston, AC; Schaffner, CP; Smith, BM | 1 |
Batzdorf, U; Fleischmann, J; Kurtz, TO; Morgan, D; Stern, WE; Winston, DJ | 1 |
Scholer, HJ | 1 |
Bolard, J; Brajtburg, J; Kobayashi, GS; Medoff, G | 1 |
Jaeger, LA; Richardson, RC; Wigle, W | 1 |
Batteiger, BE; Sathapatayavongs, B; Slama, TG; Wass, JL; Wheat, J | 1 |
Buechner, HA; Cook, EW; Thiele, JS | 1 |
Drutz, DJ; Graybill, JR; Kaster, SR | 1 |
Berman, JD; Langreth, SG; Lee, LS; Riordan, GP | 1 |
Arai, T; Shigematsu, ML; Uno, J | 1 |
Alford, RH; Cartwright, BB | 1 |
Sturde, HC | 1 |
McFadden, HW; Miller, NG; Smith, D | 1 |
Pohjola-Sintonen, S; Ruutu, P; Tallroth, K | 1 |
Cockerill, FR; Cortese, DA; Morgan, MA; Roberts, GD | 1 |
Ahearn, DG; McGlohn, MS | 1 |
Iwen, PC; McFadden, HW; Miller, NG | 1 |
Okafor, JI; TeStrake, D; Yangco, BG | 1 |
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR | 1 |
Head, WS; O'Day, DM; Ray, WA; Robinson, RD | 1 |
Edwards, DF; Legendre, AM; Selcer, BA; Stevens, R | 1 |
Plempel, M | 1 |
Feld, R; Rusthoven, JJ; Tuffnell, PG | 1 |
García-Pérez, A; Gómez de la Concha, E; Guerra Rodríguez, P | 1 |
Martinez-Suárez, JV; Rodriguez-Tudela, JL | 1 |
Chernoff, DN; Chinn, H; Green, TL; Migliorati, CA; Silverman, S | 1 |
Hahn, K; Scheven, Ch; Scheven, M; Senf, A | 1 |
Boutros, HH; Evans, GA; Van Winckle, RB; Wasan, SM | 1 |
Hoeprich, PD | 1 |
Kneale, B; Turton, C | 1 |
Ahearn, DG; Kalya, AV | 1 |
Buffet, P; Caumes, E; Gentilini, M | 1 |
Black, WA; Garg, AK; Glezos, JD; Sekhon, AS; Stein, L; Wong, C | 1 |
Cerise, FP; Failla, PJ; Karam, GH; Summer, WR | 1 |
Cross, JT; Hickerson, SL; Yamauchi, T | 1 |
Mukherjee, A; Ramesh, V | 1 |
Belcher, KE; Law, EJ; Spencer, SA; Still, JM | 1 |
Chandra, J; Patwari, AK | 1 |
Wheat, J | 1 |
Homma, T; Kurata, H; Matsuoka, H; Nemoto, Y; Ohno, H; Park, JC; Sato, R; Takatori, K | 1 |
Craig, WA; Gudmundsson, S; Turnidge, JD; Vogelman, B | 1 |
Ancarani, F; Arzeni, D; Barchiesi, F; Del Poeta, M; Marinucci, G; Morbiducci, V; Scalise, G | 1 |
Dubé, MP; Evans, S; Heseltine, PN; Rinaldi, MG; Zawacki, B | 1 |
Bolard, J; Cohen, BE; Ramos, H; Saint-Pierre-Chazalet, M | 1 |
Bickers, DR | 1 |
Day, TA; Stucker, FJ | 1 |
Goodwin, SD; Grasela, TH; Pasko, MT; Raebel, MA; Walawander, CA | 1 |
Bailey, CJ; Cartledge, JM; Morris, SA | 1 |
Edwards, JE; Filler, SG; Swerdloff, JN | 1 |
Drew, RH | 1 |
Breeling, JL; Weinstein, L | 1 |
Chaim, W; Glezerman, M; Mazor, M; Shinwell, ES | 1 |
Briggs, N; Connolly-Stringfield, P; Hafner, R; Hamill, R; Murphy, R; Owens, S; Powderly, W; Rinaldi, M; Saag, M; Spencer, P; Squires, K; Wheat, J; Wong, B; Wulfsohn, M | 1 |
Fraser-Smith, EB; Freitas, VR; Matthews, TR | 1 |
George, F; Hernigou, A; Kazatchkine, MD; Lavarde, V; Piketty, C; Weiss, L | 1 |
Fetchick, R; Graybill, JR; Sharkey-Mathis, PK; Velez, J | 1 |
Klauss, V; Lund, OE; Miño de Kaspar, H | 1 |
Altman, A; Giller, R; Lanza, L; Menezes, AH; Peters, C; Sato, Y; Smith, RJ; Trigg, ME | 1 |
Cadranel, J; Dupont, B; Lortholary, O; Meyohas, MC; Peyramond, D; Salmon-Ceron, D; Simonin, D | 1 |
Chotmongkol, V; Jitpimolmard, S | 1 |
Bolzonella, R; Contestabile, A; Fabris, A; Gardin, C; Pellanda, MV | 1 |
Cook, GC | 1 |
Catalin, J; Durand, A; Lacarelle, B; Rajaonarison, JF; Sampol, E | 1 |
Rodríguez, MA; Salinas, MC; Welsh, O | 1 |
Dossim, A; Mijiyawa, M; Napo-Koura, G; Pitche, P; Tchangaï-Walla, K | 1 |
Bolmström, A; Messer, SA; Odds, FC; Pfaller, MA; Rex, JH | 1 |
Bloom, JD; Gerding, PA; Hamor, RE | 1 |
Boyvat, A; Geilen, CC; Orfanos, CE; Seibold, M; Tebbe, B; Wölfer, LU | 1 |
Barraviera, B; Castilho, LM; Curi, PR; Da Silva, CL; Foss, NT; Marcondes-Machado, J; Meira, DA; Mendes, RP; Pellegrino Júnior, J; Peracoli, MT; Pereira, PC; Rezkallah-Iwasso, MT; Thomazini, I | 1 |
Goswami, R; Kochupillai, N; Tandon, N; Thulkar, S | 1 |
Goldman, M; Lee, YP | 1 |
Cao, B; Samaranayake, LP; Tsang, DN; Tsang, PW; Wang, J | 1 |
Bahukova, TA; Dobrodeeva, LK | 1 |
Binns, L; Perlman, EM | 1 |
Cuenca, M; Gadea, I; Gegúndez, MI; Soriano, F; Valero, ML; Zapardiel, J | 1 |
Gøtzsche, PC; Johansen, HK | 1 |
Adeyemi-Doro, FA; Chan, RC; Cheng, AF; Cheung, SW; Ng, TK | 1 |
White, TC | 1 |
Bryce, GE; Gribble, MJ; Lepawsky, M; Phillips, P | 1 |
Evans, S; Leake, H; Ustianowski, AP | 1 |
Batura-Gabryel, H; Mlynarczyk, W; Wieczorek, U | 1 |
Bone, WD; Gray, GC; Martin, CR; Oldfield, EC; Olson, P; Schillaci, RF | 1 |
Burgaleta, C | 1 |
Bouza, E; Muñoz, P | 1 |
Fortun Abete, J | 1 |
Berenguer Berenguer, J | 1 |
Ghannoum, MA; Hawser, SP; Jessup, CJ; Norris, H | 1 |
Demitrovicova, A; Kralovicova, K; Krcmery, V; Krupova, I; Kukuckova, E; Kunova, A; Mrazova-Studena, M; Oravcova, E; Spanik, S; Stopkova-Grey, K; Trupl, J | 1 |
Balaña-Fouce, R; Cubría, JC; Ordóñez, D; Reguera, RM | 1 |
Beatty, DW; Daubenton, JD | 1 |
Dumollard, JM; Lefort, T; Seguin, P; Sokolo, R; Soulhiard, F | 1 |
Ellepola, AN; Samaranayake, LP | 5 |
Hough, I | 1 |
Arceneaux, KA; Hosgood, G; Taboada, J | 1 |
Jimenez, T; López-Jodra, O; Madrenys-Brunet, N; Siddat, M; Torres-Rodríguez, JM | 1 |
Aoussi, E; Arnavielhe, S; Bastide, JM; Combe, P; Kacou, A; Koné, M; Le Guennec, R; Mallié, M; Ménan, E; Nébavi, F | 1 |
Casal, M; Linares, MJ; Muñoz, JF; Rodríguez, FC; Solís, F; Valero, A | 1 |
Daza, RM; Martín, JE; Martín, P; Martínez, MM; Mendaza, P; Portero, F; Sánchez, G | 1 |
Akpuaka, FC; Gugnani, HC; Iregbulam, LM | 1 |
Araj, GF; Daher, NK; Tabbarah, ZA | 1 |
Berrouane, YF; Herwaldt, LA; Pfaller, MA | 1 |
Espinel-Ingroff, A; Ghannoum, MA; Killian, S; Knapp, CC; Messer, SA; Norris, HA; Pfaller, M | 1 |
Bonnet, D; Cuguillière, A; Guigay, J; Jancovici, R; L'Her, P; Le Vagueresse, R; Lonjon, T; Miltgen, J; Natali, E; Vaylet, F | 1 |
Ambroise-Thomas, P; Brion, JP; Grillot, R; Lebeau, B; Pavese, P | 1 |
Desmet, P; Raes-Wuytack, C; Swinne, D; Van Looveren, K | 1 |
Alonso-Vargas, R; Arévalo, P; Bornay-Llinares, FJ; Carrillo-Muñoz, AJ; del Valle, O; Gasser, I; Quindós, G; Ruesga, MT; Santos, P; Tur-Tur, C | 1 |
Capone, D; de Noronha Andrade, G; do Valle, AC; Lazéra, MS; Londero, AT; Monteiro, PC; Moreno, AM; Wanke, B | 1 |
Carranza, A; Carrillo, JM; Mora, L; Navarrete, M; Odio, CM | 1 |
Chang, HC; Chang, JJ; Chang, TC; Huang, AH | 1 |
Chongsuvivatwong, V; Nittayananta, W; Teanpaisan, R | 1 |
Hahn, RC; Hamdan, JS | 1 |
Govender, S; Mutasa, E; Parbhoo, AH | 1 |
Apfalter, P; Hirschl, AM; Makristathis, A; Rotter, M; Seibold, M; Willinger, B | 1 |
Andersen, CY; Byskov, AG; Lu, Z; Xia, G | 1 |
Evans, T; Muñiz, AE | 1 |
Guarro, J; Llop, C; Riba, MD; Sala, J | 1 |
Kibbler, CC; McWhinney, PH; Paterson, PJ; Potter, M; Prentice, HG | 1 |
García, MT; Llorente, MT; Mínguez, F; Prieto, J | 2 |
Birinci, A; Durupinar, B; Saniç, A | 1 |
Cheng, Y; Li, ML; Lu, ZX; Wang, HB; Xia, GL | 1 |
Barchiesi, F; Cogliati, M; Di Francesco, LF; Scalise, G; Tortorano, AM; Viviani, MA | 1 |
Busowski, JD; Safdar, A | 1 |
Fernández-Ballart, J; Guarro, J; Pujol, I | 1 |
Brooks, JT; Wheat, LJ | 1 |
Briand, V; Lortholary, O | 1 |
Samaranayake, LP; Samaranayake, YH; Tsang, PC; Wong, KH; Yeung, KW | 1 |
Bonito, AJ; Patton, LL; Shugars, DA | 1 |
Anil, S; Ellepola, AN; Samaranayake, LP | 1 |
Torres-Rodríguez, JM; Vivas, JR | 1 |
Azas, N; Delmas, F; Di Giorgio, C; Gasquet, M; Timon-David, P | 1 |
Ouellette, M; Papadopoulou, B; Singh, AK | 1 |
Capilla, J; Fernández-Torres, B; Guarro, J; Ortoneda, M; Pujol, I | 1 |
Alvarado, D; Díaz, MC; Silva, V | 2 |
Buc, J; Giordani, R; Regli, P | 1 |
Miguélez, S; Obrador, P; Vila, J | 1 |
Ergon, C; Ozkutuk, A; Yulug, N | 1 |
Hernandez-Divers, SJ | 1 |
Shin, S | 1 |
Alvareda, D; Silva, V; Zepeda, G | 1 |
Daneshtalab, M; Kurosawa, T; Mori, Y; Sardari, S | 1 |
Azimov, EKh; Ibishov, KG; Sultanov, GA | 1 |
Fehér, J; Lengyel, G | 1 |
Brenner, GM; Goswick, SM | 1 |
Bansal, AK; Garg, P; Gopinathan, U; Mahesh, S; Rao, GN | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Gangneux, JP; Guiguen, C; Preney, L; Théraud, M | 1 |
Junnu, V; Suvoutho, S; Tiewcharoen, S | 1 |
Al Hedaithy, SS; Fotedar, R | 1 |
Andrade, TS; Castro, LG; Cury, AE; Gimenes, VM; Nunes, RS | 1 |
Abbasoğlu, U; Cesur, S; Citak, S; Içli, F; Ozçelik, B | 1 |
Anagnostopolous, I; Gleissner, B; Schilling, A; Siehl, I; Thiel, E | 1 |
Andreoni, S; Faggi, E; Farina, C; Fazii, P; Lombardi, G; Manso, E; Mazzoni, A; Nanetti, A; Pini, G | 1 |
Pyun, MS; Shin, S | 1 |
Bartlett, KH; Fairfax, TM; Kowalewich, NJ; Krockenberger, MB; Lester, SJ; Malik, R | 1 |
Alvarez, N; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F | 1 |
Yasuda, MA | 1 |
Barker, KS; Homayouni, R; Lee, RE; Liu, TT; Rogers, PD; Wei, L | 1 |
Abbasoglu, U; Kalkanci, A; Kaynak, F; Kustimur, S; Ozkan, S | 1 |
Ayala-Lugo, R; Barbosa, L; de Kaspar, HM; Sanchez-Di Martino, D; Sonego-Krone, S; Ta, CN; Torres-Alvariza, G | 1 |
Alía-Aponte, C; Baró-Tomás, T; Jiménez-Cabello, T; Lázera, MS; Morera-López, Y; Torres-Rodríguez, JM | 1 |
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW | 1 |
Hector, RF | 1 |
Andrade, GM; Nogueira, MG; Tonelli, E | 1 |
Chen, ZJ; Lü, XF; Pang, GR; Song, JZ; Sun, ST; Xu, Y | 1 |
Hamimah, H; Ng, KP; Rohani, MY; Tanty Haryanty, T; Tay, ST | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Chen, L; Jin, Q; Leng, W; Li, R; Liu, T; Peng, J; Wang, L; Yang, J; Yu, L; Zhang, W | 1 |
Bagyalakshmi, R; Deepa, P; Madhavan, HN; Therese, KL | 1 |
Garg, A; Kasliwal, MK; Mridha, AR; Sai Kiran, NA; Sharma, BS; Sharma, MC; Suri, A; Suri, V | 1 |
Afsar, N; Foroutan, AR; Javadi, MA; Kamel, MR; Kanavi, MR | 1 |
Chaminade, P; Fournet, A; Hocquemiller, R; Lagoutte, D; Libong, D; Loiseau, PM; Nicolas, V; Poupon, E | 1 |
Carrillo-Muñoz, AJ; Casals, JB; del Valle, O; Estivill, MD; Ezkurra, PA; Giusiano, G; Quindós, G; Santos, P | 1 |
Campbell, B; Chan, K; Kim, J; Mahoney, N; May, G; Molyneux, R | 1 |
Cruz, AR; Gallin, JI; Huang, CY; Zarember, KA | 1 |
Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
Billack, B; Lau-Cam, C; Santoro, M | 1 |
Brilhante, RS; Cordeiro, Rde A; de Camargo, ZP; de Lima, RA; Medrano, DJ; Monteiro, AJ; Rocha, MF; Sidrim, JJ; Tavares, JL | 1 |
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
Hwang, JK; Lee, K; Lee, MS; Rukayadi, Y; Yong, D | 1 |
Jayatilake, JA; Samaranayake, LP; Samaranayake, YH; Thein, ZM; Yau, JY; Yeung, KW | 1 |
Cummings, ED; Hilliard, GM; Hoehamer, CF; Rogers, PD | 1 |
Fedorko, DP; Mahanty, S; Nash, TE; Ramanathan, R; Talaat, KR | 1 |
Blanche, S; Dupont, B | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Prasad, R; Sharma, M | 1 |
Al-Nawas, B; Karbach, J; Walter, C | 1 |
Dias Filho, BP; Kaneshima, EN; Nakamura, CV; Sarragiotto, MH; Silva, SO; Tonin, LT; Ueda-Nakamura, T; Valdez, RH; Yamada-Ogatta, SF; Yamauchi, LM | 1 |
Foroumadi, A; Hosseini, NM; Massarrat, S; Pedramnia, S; Saniee, P; Siavoshi, F; Tavakolian, A | 1 |
Chen, TC; Chen, YC; Chen, YH; Lu, PL | 1 |
Bielecki, J; Jagielski, T; Kwiatkowski, S; Zak, I | 1 |
Ben Brahim, H; Ben Romdhane, F; Chakroun, M; Hadhri, R; Harrathi, K; Koubaa, J; Larbi Ammari, F; Loussaief, C; Toumi, A | 1 |
Bulut, Y; Tunçoğlu, E; Yenişehirli, A; Yenişehirli, G | 1 |
Cervi, L; Espósito, E; Maccio, JP; Monti, R; Serra, HM; Urrets-Zavalía, JA | 1 |
Bailey, CJ; French, S; Fu, J; Langlois, DK; Nelson, NC; Peterson, SW; Sutton, DA; Swenson, CL; Thompson, EH; Vilar-Saavedra, P; Wickes, BL; Wiederhold, NP | 1 |
Chandy, R; Ellepola, AN; Khan, ZU | 1 |
Bandara, HM; Ellepola, AN; Joseph, BK; Khan, ZU; Samaranayake, LP | 1 |
Al-Zahrani, AH; Ali, A; Gondal, MA; Randhawa, MA; Rashid, SG | 1 |
Fong, PH; Lee, VH; Seneviratne, CJ; Wong, SS | 1 |
Ellepola, AN; Jayathilake, JA; Khan, ZU; Sharma, PN | 1 |
Bulanda, M; Jagielski, T; Skóra, M | 1 |
Kazempour, N; Mahboubi, M | 1 |
Alves, GS; Bentes, Ados S; de Souza, JV; Freire, AK; Jackisch-Matsuura, AB; Matsuura, T; Pinheiro, JF; Wanke, B | 1 |
Atashili, J; Eba, M; Fuh, AN; Kwenti, ET; Mouliom, RN; Nchanji, GT; Njunda, AL | 1 |
Chen, C; Han, HS; Kano, R; Noli, C | 1 |
Almeida-Paes, R; Brito-Santos, F; Figueiredo-Carvalho, MHG; Gutierrez-Galhardo, MC; Machado, ACS; Oliveira, MME; Pereira, SA; Zancopé-Oliveira, RM | 1 |
Abbasi, SA; Bokhari, H; Hussain, Z; Imran, M; Jamil, B; Khalid, T; Mukhtar Bokhari, MT; Mukhtar Bokhari, MZ; Saeed, A | 1 |
Czarnecka, J; Dahm, H; Golinska, P; Rai, M; Wypij, M | 1 |
Cueva, RA; Mhoyan, A; Sakano, H | 1 |
Milanezi, ACM; VAN DER Sand, ST; Witusk, JPD | 1 |
Acar Çevik, U; Atlı, Ö; Kaplancıklı, ZA; Karaburun, AÇ; Kaya Çavuşoğlu, B; Koparal, AS; Levent, S; Osmaniye, D; Özkay, Y; Sağlık, BN | 1 |
Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K | 1 |
Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
Almeida-Paes, R; Boechat, JS; de Oliveira, MME; de Sá Machado, AC; Gremião, IDF; Pereira, SA; Viana, PG; Zancopé-Oliveira, RM | 1 |
Chen, YT; Hsu, HM; Huang, MH; Hung, CC; Liau, JY; Tsai, PH; Yeong, EK | 1 |
Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
Alegre, L; Giusiano, G; Latorre, W; Mussin, J; Rojas, FD; Sosa, MLÁ | 1 |
Buapeth, KO; Chaisut, M; Chanchayanon, B; Indoung, S; Jantrakajorn, S; Morteh, R | 1 |
89 review(s) available for ketoconazole and amphotericin b
Article | Year |
---|---|
Tetrazole hybrids and their antifungal activities.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Mycoses; Pyridines; Pyrimidines; Quinolines; Structure-Activity Relationship; Tetrazoles | 2019 |
Insights into the chemistry and therapeutic potential of furanones: A versatile pharmacophore.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Antiviral Agents; Humans; Molecular Structure | 2019 |
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing.
Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole | 2019 |
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Disease Outbreaks; Humans; Itraconazole; Ketoconazole; United States | 1992 |
Histoplasmosis in Indianapolis.
Topics: Amphotericin B; Disease Outbreaks; Fluconazole; Histoplasmosis; Humans; Indiana; Itraconazole; Ketoconazole | 1992 |
Successful treatment of Paecilomyces varioti infection in a patient with chronic granulomatous disease and a review of Paecilomyces species infections.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Follow-Up Studies; Granulomatous Disease, Chronic; Heel; Humans; Interferon-gamma; Itraconazole; Ketoconazole; Male; Mycoses; Paecilomyces; Treatment Outcome | 1992 |
[Primary Aspergillus endocarditis. Apropos of a case and review of the international literature].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Drug Therapy, Combination; Endocarditis; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Recurrence; Reoperation | 1992 |
[Choice and monitoring of the treatment of systemic mycoses. Value and limitations of in vitro tests].
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Opportunistic Infections | 1992 |
Antifungal treatment strategy in leukemia patients.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Leukemia; Mycoses; Tomography, X-Ray Computed | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomycosis; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1992 |
[Systemic antifungal drugs].
Topics: Amphotericin B; Animals; Antifungal Agents; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Mycoses; Rabbits | 1991 |
Protothecosis: a report of two cases in Japan and a review of the literature.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Arm; Child, Preschool; Dermatomycoses; Enteritis; Female; Humans; Intestinal Mucosa; Japan; Ketoconazole; Lymph Nodes; Male; Middle Aged; Prototheca | 1992 |
[Systemic candidiasis].
Topics: Amphotericin B; Candida; Candidiasis; Decontamination; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole | 1992 |
Laboratory monitoring of antifungal chemotherapy. British Society for Antimicrobial Chemotherapy Working Party.
Topics: Adult; Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Drug Resistance; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses | 1991 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
North American blastomycosis.
Topics: Amphotericin B; Blastomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Radiography | 1991 |
Pharmacology and pharmacokinetics of traditional systemic antifungal agents.
Topics: Amphotericin B; Flucytosine; Humans; Ketoconazole; Miconazole | 1990 |
[Systemic mycotic infections].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1990 |
Amphotericin B. Still the 'gold standard' for antifungal therapy.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Humans; Ketoconazole; Mycoses; Risk Factors | 1990 |
Oropharyngeal histoplasmosis.
Topics: Adult; Amphotericin B; Child; Chronic Disease; Diagnosis, Differential; Histoplasmosis; Humans; Infant; Ketoconazole; Male; Middle Aged; Tongue Diseases; Tongue Neoplasms | 1990 |
Coccidioidomycosis.
Topics: Amphotericin B; Coccidioides; Coccidioidomycosis; Humans; Immune Tolerance; Ketoconazole; Lung Diseases, Fungal; Risk Factors | 1989 |
Blastomycosis.
Topics: Amphotericin B; Blastomyces; Blastomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Spores, Fungal | 1989 |
Diagnosis and management of histoplasmosis.
Topics: Amphotericin B; Histoplasma; Histoplasmosis; Humans; Immune Tolerance; Ketoconazole; Time Factors; United States | 1989 |
Bipolaris: a serious new fungal pathogen of the paranasal sinus.
Topics: Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Mycoses; Paranasal Sinus Diseases | 1989 |
Non-chemotherapeutic agents that potentiate chemotherapy efficacy.
Topics: Adult; Amphotericin B; Animals; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Calcium Channel Blockers; Calmodulin; Cardiotonic Agents; Child; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Methionine Sulfoximine; Mice; Neoplasms; Nitroimidazoles; Xanthines | 1989 |
Opportunistic fungal infections in immunocompromised hosts.
Topics: Amphotericin B; Dermatomycoses; Flucytosine; Humans; Immunosuppression Therapy; Ketoconazole; Opportunistic Infections | 1989 |
Coccidioidomycosis.
Topics: Adult; Age Factors; Amphotericin B; Arizona; Biopsy; Child; Child, Preschool; Coccidioidomycosis; Dermatomycoses; Female; Humans; Immune Tolerance; Ketoconazole; Male; Pregnancy; Serologic Tests; Sex Factors; Skin Tests | 1989 |
Blastomycosis.
Topics: Amphotericin B; Blastomyces; Blastomycosis; Cells, Cultured; Diagnosis, Differential; Disease Outbreaks; Female; Humans; Ketoconazole; Male; Prognosis; Rural Health; Sex Factors; Time Factors; United States | 1989 |
Systemic candidiasis.
Topics: Amphotericin B; Candidiasis; Flucytosine; Humans; Immune Tolerance; Ketoconazole; Neoplasms; Opportunistic Infections; Risk Factors | 1989 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Miconazole | 1986 |
Pulmonary blastomycosis: a case report and review of the literature.
Topics: Aged; Amphotericin B; Blastomyces; Blastomycosis; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Prognosis | 1988 |
Systemic fungal infections: diagnosis and treatment. I. Therapeutic agents.
Topics: Amphotericin B; Antifungal Agents; Humans; Ketoconazole; Mycoses; Triazoles | 1988 |
Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis.
Topics: Amphotericin B; Coccidioidomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Meningitis | 1988 |
Treatment of coccidioidomycosis.
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Humans; Ketoconazole | 1988 |
Treatment of histoplasmosis and blastomycosis.
Topics: Amphotericin B; Blastomycosis; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal | 1988 |
Topical and systemic antifungal agents.
Topics: Administration, Topical; Amphotericin B; Antifungal Agents; Dermatomycoses; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1988 |
Deep fungal infections in the elderly.
Topics: Age Factors; Aged; Amphotericin B; Blastomycosis; Coccidioidomycosis; Histoplasmosis; Humans; Ketoconazole; Recurrence; Sporotrichosis; United States | 1988 |
Systemic mycosis due to Penicillium marneffei in a patient with antibody to human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Penicillium | 1988 |
Genitourinary coccidioidomycosis.
Topics: Adult; Amphotericin B; Coccidioidomycosis; Genital Diseases, Male; Humans; Hydronephrosis; Intestinal Fistula; Ketoconazole; Male; Prostatic Diseases; Sigmoid Diseases; Urinary Bladder Diseases; Urinary Bladder Fistula | 1988 |
[Paracoccidioidomycosis in Japan].
Topics: Adult; Amphotericin B; Drug Therapy, Combination; Female; Humans; Japan; Ketoconazole; Paracoccidioidomycosis | 1987 |
Pulmonary sporotrichosis: review of treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Middle Aged; Pneumonectomy; Radiography; Sporotrichosis; Tuberculosis, Pulmonary | 1986 |
Cutaneous and mucosal manifestations of the deep mycotic infections.
Topics: Amphotericin B; Aspergillosis; Blastomycosis; Candidiasis; Candidiasis, Cutaneous; Coccidioidomycosis; Cryptococcosis; Dermatomycoses; Flucytosine; Histoplasmosis; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mouth Diseases; Mouth Mucosa; Mucormycosis; Mycoses; Paracoccidioidomycosis; Sporotrichosis; Travel | 1986 |
Prophylaxis of mycotic infections in immunocompromised patients: a review of 27 reports and publications.
Topics: Amphotericin B; Drug Administration Schedule; Humans; Immunosuppression Therapy; Ketoconazole; Miconazole; Mycoses; Nystatin | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Cryptococcosis; Dog Diseases; Dogs; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal; Pneumonia | 1985 |
The current status of systemic antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Griseofulvin; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
Current management of fungal enteritis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Diarrhea; Enteritis; Histoplasmosis; Humans; Imidazoles; Immunosuppression Therapy; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin; Paracoccidioidomycosis; Piperazines; Sulfadiazine | 1982 |
[Systemic antimycotic treatment].
Topics: Amphotericin B; Drug Therapy, Combination; Flucytosine; Griseofulvin; Humans; Imidazoles; Iodides; Ketoconazole; Miconazole; Mycoses; Piperazines; Transfer Factor | 1982 |
Antifungal agents used in systemic mycoses. Activity and therapeutic use.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Imidazoles; Ketoconazole; Kidney; Kidney Diseases; Kinetics; Miconazole; Mycoses; Piperazines | 1983 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; Coccidioidomycosis; Cryptococcosis; Flucytosine; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Mycoses; Nausea; Piperazines; Vomiting | 1983 |
[Chemotherapy of aspergillus lung disease].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Piperazines | 1983 |
Antifungal agents useful in therapy of systemic fungal infections.
Topics: Amphotericin B; Animals; Antifungal Agents; Binding, Competitive; Cholesterol; Ergosterol; Flucytosine; Fungi; Humans; Imidazoles; Ketoconazole; Membranes, Artificial; Miconazole; Mycoses; Phospholipids; Piperazines; Sterols | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin | 1984 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
[Treatment of localized cutaneous leishmaniasis].
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine | 1994 |
Antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses | 1995 |
Post-kala-azar dermal leishmaniasis.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Humans; Incidence; Ketoconazole; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral | 1995 |
Diagnosis and treatment of kala-azar.
Topics: Allopurinol; Amphotericin B; Antimony Sodium Gluconate; Child; Combined Modality Therapy; Humans; Ketoconazole; Leishmaniasis, Visceral; Pentamidine; Predictive Value of Tests; Reproducibility of Results; Sensitivity and Specificity; Splenectomy | 1994 |
Histoplasmosis: recognition and treatment.
Topics: Amphotericin B; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Serologic Tests | 1994 |
Antifungal therapy: potential interactions with other classes of drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Griseofulvin; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Is there a correlation between serum antifungal drug concentration and clinical outcome?
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Humans; Injections, Intravenous; Itraconazole; Ketoconazole; Liver; Microbial Sensitivity Tests; Mycoses; Piperazines; Risk Factors; Treatment Outcome | 1994 |
Treatment of coccidioidomycosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Humans; Ketoconazole; Lung Diseases, Fungal | 1993 |
A clinician's view of blastomycosis.
Topics: Adult; Amphotericin B; Blastomycosis; Child; Female; Humans; Itraconazole; Ketoconazole; Male | 1993 |
Pharmacotherapy of disseminated histoplasmosis in patients with AIDS.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; United States | 1993 |
Treatment of eumycetoma and actinomycetoma.
Topics: Actinomycetales; Amphotericin B; Antifungal Agents; Humans; Itraconazole; Ketoconazole; Mycetoma; Nocardia; Streptomyces | 1995 |
The role of azole antifungal agents for systemic antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Drug Costs; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole | 1997 |
Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropenia.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Neoplasms; Neutropenia; Randomized Controlled Trials as Topic | 1997 |
Therapy of blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Dose-Response Relationship, Drug; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Recurrence; Treatment Outcome | 1997 |
[Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Candidiasis; Candidiasis, Chronic Mucocutaneous; Clinical Trials as Topic; Cryptococcosis; Double-Blind Method; Fluconazole; Humans; Itraconazole; Ketoconazole; Mucormycosis; Mycoses; Neutropenia; Nystatin; Primary Prevention; Recurrence; Retrospective Studies | 1995 |
[Prevention and treatment of fungal infections in solid-organ transplant recipients].
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Heart Transplantation; Humans; Itraconazole; Ketoconazole; Kidney Transplantation; Liver Transplantation; Lung Transplantation; Multicenter Studies as Topic; Mycoses; Pancreas Transplantation; Risk Factors; Transplantation | 1995 |
[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Clinical Trials as Topic; Cryptococcosis; Drug Resistance, Microbial; Esophageal Diseases; Female; Fluconazole; Fungi; Humans; Ketoconazole; Male; Retrospective Studies | 1995 |
[Commonly used antifungal agents in the treatment of systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Clinical Trials as Topic; Coccidioidomycosis; Cryptococcosis; Fluconazole; Flucytosine; Hematologic Diseases; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney; Mycoses; Thrombophlebitis | 1995 |
The pharmacology of leishmaniasis.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Itraconazole; Ketoconazole; Leishmania; Leishmaniasis; Paromomycin; World Health Organization | 1998 |
[Paranasal mucormycosis with involvement of the sphenoid sinus].
Topics: Aged; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Diabetes Mellitus, Type 1; Female; Humans; Insulin; Ketoconazole; Mucormycosis; Nose Diseases; Orbital Diseases; Sphenoid Sinusitis | 1998 |
African histoplasmosis: report of two patients treated with amphotericin B and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Male; Treatment Outcome | 1998 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Paracoccidioidomycosis; Penicillium; Sporotrichosis; Sulfadiazine; Travel; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
[American pulmonary histoplasmosis caused by Histoplasma capsulatum].
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Australia; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; Histoplasma; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Latin America; Lung Diseases, Fungal; Radiography, Thoracic; Tomography, X-Ray Computed; United States | 1998 |
Antimycotic agents in oral candidosis: an overview: 2. Treatment of oral candidosis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Clotrimazole; Drug Interactions; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Nystatin; Virulence | 2000 |
A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Clotrimazole; Databases as Topic; Fluconazole; HIV Seropositivity; Humans; Itraconazole; Ketoconazole; Nystatin; Oropharynx; Pharyngeal Diseases; Randomized Controlled Trials as Topic; Research Design; Statistics as Topic; Treatment Outcome | 2001 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
[Therapeutic safety of antimycotics in the treatment of systemic fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Liver; Mycoses | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Improved outcome of zygomycosis in patients with hematological diseases?
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Aspergillus fumigatus; Combined Modality Therapy; Deoxycholic Acid; Ethmoid Sinusitis; Female; Hematologic Diseases; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Liposomes; Lymphoma, Large B-Cell, Diffuse; Male; Maxillary Sinusitis; Middle Aged; Mucor; Mucormycosis; Multiple Myeloma; Nose Diseases; Opportunistic Infections; Prognosis; Treatment Outcome; Zygomycosis | 2004 |
Pharmacological management of paracoccidioidomycosis.
Topics: Amphotericin B; Central Nervous System Fungal Infections; Drug Resistance; Fluconazole; Follow-Up Studies; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Paracoccidioidomycosis; Pyrimidines; Sulfonamides; Triazoles; Voriconazole | 2005 |
An overview of antifungal drugs and their use for treatment of deep and superficial mycoses in animals.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus; Candida; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Severity of Illness Index | 2005 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
18 trial(s) available for ketoconazole and amphotericin b
Article | Year |
---|---|
Itraconazole compared with amphotericin B plus flucytosine in AIDS patients with cryptococcal meningitis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged; Opportunistic Infections; Prospective Studies; Survival Analysis | 1992 |
Itraconazole in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Humans; Itraconazole; Ketoconazole; Mycoses; Neutropenia | 1992 |
The treatment of kala-azar: old and new options.
Topics: Amphotericin B; Antimony; Humans; Ketoconazole; Leishmaniasis, Visceral; Paromomycin | 1992 |
[Therapy of systemic mycoses in neutropenic patients using itraconazole. A comparative, randomized study with amphotericin B].
Topics: Adolescent; Agranulocytosis; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Candidiasis; Humans; Itraconazole; Ketoconazole; Male; Mycoses | 1991 |
The efficacy of itraconazole against systemic fungal infections in neutropenic patients: a randomised comparative study with amphotericin B.
Topics: Amphotericin B; Aspergillosis; Aspergillus fumigatus; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Neutropenia; Prospective Studies | 1991 |
Antifungal chemoprophylaxis in cancer children: a prospective randomized controlled study.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Feces; Female; Humans; Infant; Itraconazole; Ketoconazole; Male; Mycoses; Neoplasms; Pharynx; Prospective Studies | 1990 |
Amphotericin B vs high-dose ketoconazole for empirical antifungal therapy among febrile, granulocytopenic cancer patients. A prospective, randomized study.
Topics: Adult; Agranulocytosis; Amphotericin B; Fever; Humans; Immune Tolerance; Ketoconazole; Mycoses; Neoplasms; Prospective Studies | 1991 |
Does ketoconazole prevent fungal infection in children treated with high dose chemotherapy and bone marrow transplantation? Results of a randomized placebo-controlled trial.
Topics: Amphotericin B; Bone Marrow Transplantation; Child; Child, Preschool; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Ketoconazole; Male; Mycoses | 1991 |
Collaborative investigation of variables in susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Cell Division; Culture Media; Evaluation Studies as Topic; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Microbiological Techniques; Temperature; Time Factors | 1990 |
Non-chemotherapeutic agents that potentiate chemotherapy efficacy.
Topics: Adult; Amphotericin B; Animals; Antimetabolites; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Buthionine Sulfoximine; Calcium Channel Blockers; Calmodulin; Cardiotonic Agents; Child; Clinical Trials as Topic; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Synergism; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Methionine Sulfoximine; Mice; Neoplasms; Nitroimidazoles; Xanthines | 1989 |
Amphotericin B or ketoconazole therapy of fungal infections in neutropenic cancer patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Female; Humans; Ketoconazole; Male; Middle Aged; Mycoses; Neoplasms; Neutropenia; Prospective Studies; Random Allocation | 1987 |
Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients.
Topics: Amphotericin B; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Imidazoles; Immunosuppressive Agents; Ketoconazole; Leukemia; Mycoses; Neutropenia; Nystatin; Piperazines; Random Allocation | 1982 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Adolescent; Adult; Amphotericin B; Antineoplastic Agents; Candidiasis, Oral; Candidiasis, Vulvovaginal; Drug Therapy, Combination; Female; Humans; Ketoconazole; Leukemia, Myeloid; Male; Middle Aged; Neutropenia; Random Allocation | 1984 |
Prophylaxis of fungal infections in neutropenic cancer patients.
Topics: Agranulocytosis; Amphotericin B; Aspergillosis; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Neoplasms; Neutropenia; Nystatin; Patient Isolation | 1983 |
Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of fungal infections.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Humans; Ketoconazole; Miconazole; Mycoses; Neoplasms; Nystatin | 1984 |
Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Female; Histoplasma; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Patient Compliance; Prospective Studies; Recurrence | 1993 |
The use of glucan as immunostimulant in the treatment of paracoccidioidomycosis.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Antibodies, Fungal; Antifungal Agents; beta-Glucans; Blood Sedimentation; CD3 Complex; CD4 Antigens; CD4 Lymphocyte Count; CD4-CD8 Ratio; CD8 Antigens; Drug Therapy, Combination; Glucans; Humans; Immunization; Ketoconazole; Male; Middle Aged; Paracoccidioides; Paracoccidioidomycosis; Phytohemagglutinins; Skin Tests; Sulfadiazine; Sulfanilamides; T-Lymphocyte Subsets; Trimethoprim, Sulfamethoxazole Drug Combination; Tumor Necrosis Factor-alpha | 1996 |
Oropharyngeal candidiasis in AIDS patients from Abidjan (Ivory Coast): antifungal susceptibilities and multilocus enzyme electrophoresis analysis of Candida albicans isolates.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Cote d'Ivoire; Drug Resistance, Microbial; Fungal Proteins; Genetic Variation; Humans; Ketoconazole; Middle Aged; Nystatin; Phylogeny; Treatment Outcome | 1998 |
499 other study(ies) available for ketoconazole and amphotericin b
Article | Year |
---|---|
Synthesis, biological evaluation and quantitative structure-active relationships of 1,3-thiazolidin-4-one derivatives. A promising chemical scaffold endowed with high antifungal potency and low cytotoxicity.
Topics: Antifungal Agents; Candida; Carbon-13 Magnetic Resonance Spectroscopy; Drug Screening Assays, Antitumor; Gram-Negative Bacteria; Gram-Positive Bacteria; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Proton Magnetic Resonance Spectroscopy; Quantitative Structure-Activity Relationship; Thiazolidines | 2017 |
Combating Drug-Resistant Fungi with Novel Imperfectly Amphipathic Palindromic Peptides.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Cytoplasm; Drug Resistance, Fungal; HEK293 Cells; Hemolysis; Humans; Hydrophobic and Hydrophilic Interactions; Intracellular Membranes; Inverted Repeat Sequences; Mice; Models, Molecular; Peptides; Protein Conformation; RAW 264.7 Cells | 2018 |
Design, synthesis and bio-evaluation of C-1 alkylated tetrahydro-β-carboline derivatives as novel antifungal lead compounds.
Topics: Alkylation; Amphotericin B; Antifungal Agents; Candida; Carbolines; Cell Survival; Cryptococcus neoformans; Drug Design; Drug Synergism; Fluconazole; HEK293 Cells; Humans; Kinetics; Microbial Sensitivity Tests; Structure-Activity Relationship | 2020 |
Design, synthesis, and biodistribution studies of new analogues of marine alkaloids: Potent in vitro and in vivo fungicidal agents against Candida spp.
Topics: Alkaloids; Antifungal Agents; Candida; Dose-Response Relationship, Drug; Drug Design; Fungicides, Industrial; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2021 |
Synthesis, specificity, and antifungal activity of inhibitors of the Candida albicans delta 24-sterol methyltransferase.
Topics: Antifungal Agents; Candida albicans; Cholesterol; Enzyme Inhibitors; Lanosterol; Methyltransferases; Microbial Sensitivity Tests; Structure-Activity Relationship | 1992 |
In vitro evaluation of antifungal properties of 8.O.4'-neolignans.
Topics: Antifungal Agents; Epidermophyton; Lignans; Microbial Sensitivity Tests; Microsporum; Spectrum Analysis; Trichophyton | 1997 |
DNA-damaging steroidal alkaloids from Eclipta alba from the suriname rainforest1.
Topics: Alkaloids; Asteraceae; Candida albicans; Cell Line; DNA; DNA Damage; India; Magnetic Resonance Spectroscopy; Phytosterols; Plants, Medicinal; Saccharomyces cerevisiae; Suriname | 1998 |
Antimicrobial and antitumor activities of mycosporulone.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Bacteria; Cyclohexanes; Drug Screening Assays, Antitumor; Fungi; Humans; Microbial Sensitivity Tests; Spiro Compounds; Tumor Cells, Cultured | 1999 |
In vitro evaluation of antifungal properties of phenylpropanoids and related compounds acting against dermatophytes.
Topics: Antifungal Agents; Arthrodermataceae; Drug Evaluation; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Phenylpropionates; Structure-Activity Relationship | 1999 |
Suitably functionalised pyrimidines as potential antimycotic agents.
Topics: Antifungal Agents; Fungi; Humans; Microbial Sensitivity Tests; Pyrimidines; Species Specificity | 2000 |
3-Phenyl-5-acyloxymethyl-2H,5H-furan-2-ones: synthesis and biological activity of a novel group of potential antifungal drugs.
Topics: 4-Butyrolactone; Amphotericin B; Antifungal Agents; Fungi; Furans; Humans; Microbial Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 2001 |
Novel endoperoxides: synthesis and activity against Candida species.
Topics: Candida; Microbial Sensitivity Tests; Molecular Conformation; Peroxides; Species Specificity; Stereoisomerism | 2006 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.
Topics: Antifungal Agents; Computer Simulation; Drug Design; Microbial Sensitivity Tests; Microwaves; Mitosporic Fungi; Molecular Structure; Rhodanine; Sensitivity and Specificity; Stereoisomerism; Structure-Activity Relationship; Yeasts | 2007 |
Design of endoperoxides with anti-Candida activity.
Topics: Animals; Antifungal Agents; Candida albicans; Cell Proliferation; CHO Cells; Cricetinae; Drug Design; Erythrocytes; Humans; Microbial Sensitivity Tests; Molecular Conformation; Peroxides; Stereoisomerism; Structure-Activity Relationship | 2007 |
Reduced susceptibility to polyenes associated with a missense mutation in the ERG6 gene in a clinical isolate of Candida glabrata with pseudohyphal growth.
Topics: Antifungal Agents; Candida glabrata; Candidiasis; DNA Primers; Genes, Fungal; Genetic Complementation Test; Methyltransferases; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation, Missense; Phenotype; Polyenes; Reverse Transcriptase Polymerase Chain Reaction; RNA, Fungal; RNA, Messenger; Sterols | 2007 |
A Candida albicans petite mutant strain with uncoupled oxidative phosphorylation overexpresses MDR1 and has diminished susceptibility to fluconazole and voriconazole.
Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Candida albicans; Drug Resistance, Fungal; Fluconazole; Microbial Sensitivity Tests; Mutation; Oxidative Phosphorylation; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Voriconazole | 2007 |
Synthesis of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase (CYP51).
Topics: Antifungal Agents; Cytochrome P-450 Enzyme System; Enzyme Inhibitors; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Infrared; Triazoles | 2007 |
Discovery of novel indazole-linked triazoles as antifungal agents.
Topics: Administration, Oral; Animals; Antifungal Agents; Aspergillus; Candida; Disease Models, Animal; Indazoles; Mice; Microbial Sensitivity Tests; Rats; Stereoisomerism; Triazoles | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Role for cell density in antifungal drug resistance in Candida albicans biofilms.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests | 2007 |
Treatment of a clinically relevant plant-pathogenic fungus with an agricultural azole causes cross-resistance to medical azoles and potentiates caspofungin efficacy.
Topics: Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Colletotrichum; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fungi; Fungicides, Industrial; Humans; In Vitro Techniques; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Fluorescence; Nystatin; Plant Diseases; Skin; Triazoles | 2007 |
The Ssk1p response regulator and Chk1p histidine kinase mutants of Candida albicans are hypersensitive to fluconazole and voriconazole.
Topics: Antifungal Agents; Candida albicans; Culture Media; Drug Resistance, Fungal; Fluconazole; Histidine Kinase; Microbial Sensitivity Tests; Mutation; Phenotype; Phosphorylation; Protein Kinases; Pyrimidines; Signal Transduction; Triazoles; Voriconazole | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
N-Phenyl and N-phenylalkyl-maleimides acting against Candida spp.: time-to-kill, stability, interaction with maleamic acids.
Topics: Antifungal Agents; Candida; Maleates; Maleimides; Microbial Sensitivity Tests; Spectrum Analysis; Time Factors | 2008 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Reliability of the WIDERYST susceptibility testing system for detection of in vitro antifungal resistance in yeasts.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Culture Media; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Reproducibility of Results; Yeasts | 2008 |
In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Fusarium; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles; Tubulin | 2008 |
Penetratin and derivatives acting as antifungal agents.
Topics: Amino Acid Sequence; Antifungal Agents; Candida albicans; Carrier Proteins; Cell-Penetrating Peptides; Cryptococcus neoformans; Humans; Molecular Conformation; Oligopeptides; Structure-Activity Relationship | 2009 |
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.
Topics: Antifungal Agents; Biofilms; Candida albicans; Cell Adhesion; Colony Count, Microbial; Culture Media; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Polystyrenes; Time Factors | 2008 |
A nonsense mutation in the ERG6 gene leads to reduced susceptibility to polyenes in a clinical isolate of Candida glabrata.
Topics: Antifungal Agents; Azoles; Base Sequence; Candida glabrata; Candidiasis; Codon, Nonsense; DNA, Fungal; Drug Resistance, Fungal; Ergosterol; Genes, Fungal; Guanine; Humans; Molecular Sequence Data; Polyenes | 2008 |
In vitro antifungal activity of polyfunctionalized 2-(hetero)arylquinolines prepared through imino Diels-Alder reactions.
Topics: Acids; Antifungal Agents; Arthrodermataceae; Candida; Catalysis; Cryptococcus; Dose-Response Relationship, Drug; Imines; Microbial Sensitivity Tests; Molecular Structure; Quinolines; Stereoisomerism; Structure-Activity Relationship | 2008 |
Evidence for the mechanism of action of the antifungal phytolaccoside B isolated from Phytolacca tetramera Hauman.
Topics: Antifungal Agents; Argentina; Cell Membrane; Cell Wall; Glucosyltransferases; Glycosides; Humans; Microscopy, Fluorescence; Oleanolic Acid; Phytolacca; Plants, Medicinal; Saccharomyces cerevisiae; Saponins; Triterpenes | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Synthesis and antifungal activity of 1,2,3-triazole containing fluconazole analogues.
Topics: Animals; Antifungal Agents; Bile Acids and Salts; Candida albicans; Candidiasis; Cell Line, Tumor; Chemistry, Pharmaceutical; Drug Design; Drug Screening Assays, Antitumor; Fluconazole; Humans; Inhibitory Concentration 50; Mice; Models, Chemical; Triazoles | 2009 |
Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Topics: Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Candida albicans; Drug Resistance, Fungal; Fluconazole; Fungal Proteins; Itraconazole; Ketoconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Rhodamines | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
Relation between lipophilicity of alkyl gallates and antifungal activity against yeasts and filamentous fungi.
Topics: Antifungal Agents; Arthrodermataceae; Chemistry, Pharmaceutical; Drug Design; Drug Evaluation, Preclinical; Ergosterol; Fungi; Gallic Acid; Microbial Sensitivity Tests; Microsporum; Molecular Structure; Structure-Activity Relationship | 2009 |
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.
Topics: Adult; Aerobiosis; Antifungal Agents; Azoles; Candida glabrata; Chromatography, High Pressure Liquid; Ergosterol; Female; Flow Cytometry; Genes, Fungal; Humans; Microbial Sensitivity Tests; Microscopy, Electron, Transmission; Molecular Sequence Data; Polyenes | 2009 |
5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene.
Topics: Animals; Chagas Disease; Drug Design; Humans; Mice; Nitrofurans; Quantitative Structure-Activity Relationship; Squalene; Squalene Monooxygenase; Thiophenes; Trypanocidal Agents; Trypanosoma cruzi | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
New small-size peptides possessing antifungal activity.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; Candida albicans; Candidiasis; Cryptococcosis; Cryptococcus neoformans; Models, Molecular; Mycoses; Peptides; Poecilia; Toxicity Tests, Acute | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Naftifine-analogues as anti-Trypanosoma cruzi agents.
Topics: Allylamine; Animals; Cell Line; Drug Design; Fungi; Inhibitory Concentration 50; Mice; Microbial Sensitivity Tests; Squalene; Trypanocidal Agents; Trypanosoma cruzi | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A clinical isolate of Candida albicans with mutations in ERG11 (encoding sterol 14alpha-demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Drug Resistance, Fungal; Fungal Proteins; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
New antifungal peptides. Synthesis, bioassays and initial structure prediction by CD spectroscopy.
Topics: Amino Acid Sequence; Antifungal Agents; Candida albicans; Circular Dichroism; Cryptococcus neoformans; Microbial Sensitivity Tests; Molecular Sequence Data; Peptides; Protein Structure, Secondary | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Identification and characterization of four azole-resistant erg3 mutants of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Clotrimazole; Drug Resistance, Fungal; Ergosterol; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mutation; Oxidoreductases; Pyrimidines; Triazoles; Voriconazole | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Penetratin analogues acting as antifungal agents.
Topics: Amino Acid Sequence; Antifungal Agents; Carrier Proteins; Cell-Penetrating Peptides; Circular Dichroism; Fungi; Molecular Dynamics Simulation; Molecular Sequence Data; Monte Carlo Method; Protein Conformation; Static Electricity | 2011 |
Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.
Topics: Adenosine Triphosphate; Aminoquinolines; Antiprotozoal Agents; Drug Resistance; Glycolysis; Leishmania major; Pyruvate Kinase | 2011 |
Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives.
Topics: Antifungal Agents; Candida albicans; Catalytic Domain; Cryptococcus neoformans; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Piperazines; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles; Voriconazole | 2011 |
Antifungal, cytotoxic and SAR studies of a series of N-alkyl, N-aryl and N-alkylphenyl-1,4-pyrrolediones and related compounds.
Topics: Antifungal Agents; Maleimides; Microbial Sensitivity Tests; Quantum Theory; Static Electricity; Structure-Activity Relationship | 2011 |
New triazole derivatives as antifungal agents: synthesis via click reaction, in vitro evaluation and molecular docking studies.
Topics: Antifungal Agents; Catalysis; Catalytic Domain; Click Chemistry; Computer Simulation; Copper; Fungi; Humans; Microbial Sensitivity Tests; Triazoles | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Structure-activity relationship study of nitrosopyrimidines acting as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Candida tropicalis; Cryptococcus neoformans; Hydrogen Bonding; Microbial Sensitivity Tests; Models, Molecular; Nitroso Compounds; Pyrimidines; Quantum Theory; Structure-Activity Relationship | 2012 |
Synthesis and antifungal activity of diverse C-2 pyridinyl and pyridinylvinyl substituted quinolines.
Topics: Antifungal Agents; Candida albicans; Cryptococcus neoformans; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Pyridines; Quinolines; Structure-Activity Relationship | 2012 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds.
Topics: Antifungal Agents; Candida; Cryptococcus neoformans; DNA-Binding Proteins; Furans; Humans | 2015 |
Anti-Candida activity and cytotoxicity of a large library of new N-substituted-1,3-thiazolidin-4-one derivatives.
Topics: 14-alpha Demethylase Inhibitors; Anti-Bacterial Agents; Antifungal Agents; Candida; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Fungal Proteins; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Small Molecule Libraries; Sterol 14-Demethylase; Structure-Activity Relationship; Thiazolidines | 2016 |
Novel 1,3-thiazolidin-4-one derivatives as promising anti-Candida agents endowed with anti-oxidant and chelating properties.
Topics: Antifungal Agents; Antioxidants; Candida; Chelating Agents; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Thiazolidines; Toxicity Tests | 2016 |
Novel Terminal Bipheny-Based Diapophytoene Desaturases (CrtN) Inhibitors as Anti-MRSA/VISR/LRSA Agents with Reduced hERG Activity.
Topics: Animals; Drug Design; Enzyme Inhibitors; ERG1 Potassium Channel; HEK293 Cells; Hep G2 Cells; Humans; Inhibitory Concentration 50; Methicillin-Resistant Staphylococcus aureus; Mice; Oxidoreductases; Rats; Safety; Solubility; Structure-Activity Relationship; Water | 2018 |
In vitro susceptibility and synergy studies of Aspergillus species to conventional and new agents.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Drug Antagonism; Drug Resistance, Microbial; Drug Synergism; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses; Opportunistic Infections | 1992 |
Penicillium marneffei infection in patients infected with human immunodeficiency virus.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; HIV Infections; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mycoses; Opportunistic Infections; Penicillium; Retrospective Studies; Thailand; Treatment Outcome | 1992 |
Comparison of azoles against aspergilli in vitro and in an experimental model of pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Disease Models, Animal; Itraconazole; Ketoconazole; Male; Rats; Rats, Inbred Strains; Triazoles | 1992 |
In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Fluconazole; Flucytosine; Guinea Pigs; Immunocompromised Host; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Sporotrichosis | 1992 |
Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pseudallescheria | 1992 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Ventriculitis and hydrocephalus caused by Candida albicans successfully treated by antimycotic therapy and cerebrospinal fluid shunting.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Abscess; Candidiasis; Cerebral Ventricles; Cerebrospinal Fluid; Combined Modality Therapy; Drug Therapy, Combination; Female; Flucytosine; Humans; Hydrocephalus; Itraconazole; Ketoconazole; Ventriculoperitoneal Shunt | 1992 |
Aspergillus-induced discitis. A role for itraconazole in therapy?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Discitis; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male | 1992 |
In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Species Specificity | 1992 |
Itraconazole in cryptococcal meningitis in pregnancy: a case report.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Infant, Newborn; Itraconazole; Ketoconazole; Meningitis, Cryptococcal; Pregnancy; Pregnancy Complications, Infectious | 1992 |
Disseminated histoplasmosis with unusual cutaneous lesions in a patient from the Philippines.
Topics: Amphotericin B; Dermatomycoses; Female; Histoplasma; Histoplasmosis; Humans; Immunocompromised Host; Ketoconazole; Lupus Erythematosus, Systemic; Middle Aged; Neutrophils; Philippines; Prednisone | 1992 |
Coccidioidomycosis in horses: 15 cases (1975-1984).
Topics: Amphotericin B; Animals; Arizona; California; Coccidioidomycosis; Female; Horse Diseases; Horses; Ketoconazole; Male; Retrospective Studies; Treatment Outcome | 1992 |
In vitro activity of cloconazole, sulconazole, butoconazole, isoconazole, fenticonazole, and five other antifungal agents against clinical isolates of Candida albicans and Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Econazole; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Evaluation of antifungal activity of antimycotics by automatic analyzing system.
Topics: Amphotericin B; Antifungal Agents; Antimycin A; Aspergillus niger; Ciclopirox; Flucytosine; Fungi; Griseofulvin; Image Processing, Computer-Assisted; Ketoconazole; Nystatin; Pyridones; Sodium Chloride | 1992 |
Blastomycotic cranial osteomyelitis.
Topics: Adult; Amphotericin B; Blastomyces; Blastomycosis; Central Nervous System; Ear, Middle; Female; Granuloma; Hearing Loss, Conductive; Humans; Ketoconazole; Magnetic Resonance Imaging; Osteomyelitis; Otitis Media; Temporal Bone; X-Rays | 1992 |
Clinical manifestation of mediastinal fibrosis and histoplasmosis.
Topics: Adolescent; Adult; Amphotericin B; Boston; Combined Modality Therapy; Esophagoplasty; Female; Fibrosis; Follow-Up Studies; Histoplasmosis; Hospital Mortality; Hospitals, General; Humans; Ketoconazole; Male; Mediastinal Diseases; Middle Aged; Pneumonectomy; Radiography; Steroids | 1992 |
Disseminated histoplasmosis presenting with ileal perforation in a renal transplant recipient.
Topics: Adult; Amphotericin B; Diagnosis, Differential; Female; Histoplasmosis; Humans; Ileal Diseases; Intestinal Perforation; Ketoconazole; Kidney Transplantation | 1992 |
[Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Flucytosine; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1992 |
Fungal keratitis after radial keratotomy.
Topics: Adult; Amphotericin B; Candidiasis; Eye Infections, Fungal; Female; Humans; Keratitis; Keratotomy, Radial; Ketoconazole | 1992 |
Recurrent Histoplasma capsulatum pneumonia: a case report.
Topics: Adult; Amphotericin B; Dust; Histoplasmosis; Humans; Ketoconazole; Male; Occupational Diseases; Pneumonia; Recurrence | 1992 |
Candida laryngotracheitis: a complication of combined steroid and antibiotic usage in croup.
Topics: Amphotericin B; Candidiasis; Candidiasis, Oral; Cefaclor; Cefuroxime; Croup; Dexamethasone; Female; Humans; Infant; Ketoconazole; Laryngitis; Tracheitis | 1992 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with systemic mycoses].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Trichosporon | 1991 |
[In vitro antifungal activity of itraconazole, a new triazole antifungal agent, against clinical isolates from patients with dermatomycoses].
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Dermatomycoses; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1991 |
In vitro comparison of cilofungin alone and in combination with other antifungal agents against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Therapy, Combination; Echinocandins; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic | 1991 |
Treatment of deep mycoses with itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Antitubercular Agents; Aspergillosis; Child; Chromoblastomycosis; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Mucormycosis | 1991 |
Candida zeylanoides: another opportunistic yeast.
Topics: Amphotericin B; Candida; Catheterization, Central Venous; DNA, Fungal; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Female; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Parenteral Nutrition, Total; Polymorphism, Restriction Fragment Length | 1991 |
Inhibiting cholesterol synthesis reduces the binding and toxicity of amphotericin B against rabbit renal tubular cells in primary culture.
Topics: Amphotericin B; Animals; Anticholesteremic Agents; Cell Membrane; Cells, Cultured; Cholesterol; Ketoconazole; Kidney Tubules; Phosphates; Rabbits | 1992 |
[Meningitis caused by Candida albicans in a male patient infected by HIV and failure of treatment with amphotericin B].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Immunocompromised Host; Ketoconazole; Male; Meningitis, Fungal | 1991 |
Disseminated histoplasmosis in AIDS patients in Maryland.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Female; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Male; Maryland; Middle Aged; Opportunistic Infections | 1991 |
Drug-resistant Nocardia asteroides infection in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Drug Resistance, Microbial; Histoplasmosis; Humans; Ketoconazole; Male; Nocardia asteroides; Nocardia Infections | 1991 |
Opportunistic infections of the esophagus not responding to oral systemic antifungals in patients with AIDS: their frequency and treatment.
Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Administration, Oral; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Esophagitis; Female; Fluconazole; Ganciclovir; Humans; Infusions, Intravenous; Ketoconazole; Male; Opportunistic Infections; Prospective Studies; Treatment Outcome | 1991 |
Treatment of cryptococcal meningitis with five anti-fungal drugs: the role of amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis; Miconazole; Middle Aged | 1990 |
Amphotericin-resistant aspergillus osteomyelitis controlled by itraconazole.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Resistance, Microbial; Food, Formulated; Humans; Itraconazole; Ketoconazole; Male; Osteomyelitis | 1990 |
Treatment of refractory oral candidiasis with fluconazole. A case report.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida albicans; Candidiasis, Oral; Clotrimazole; Deglutition Disorders; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Ketoconazole; Male | 1991 |
In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Culture Media; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Species Specificity; Yeasts | 1991 |
Intraocular tumor from disseminated histoplasmosis.
Topics: Amphotericin B; Eye Neoplasms; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged; Visual Acuity | 1991 |
The effectiveness of a preventive regimen on the periodontal health of patients undergoing chemotherapy for leukemia and lymphoma.
Topics: Acyclovir; Amphotericin B; Ceftazidime; Chlorhexidine; Dental Plaque Index; Fluconazole; Humans; Immunosuppression Therapy; Ketoconazole; Leukemia; Lymphoma; Miconazole; Norfloxacin; Periodontal Diseases; Periodontal Index; Tooth Loss; Vancomycin | 1991 |
Comment: consideration of amphotericin B hepatotoxicity.
Topics: Amphotericin B; Fatty Liver; Hepatomegaly; Humans; Ketoconazole | 1991 |
Clinical and experimental mycotic keratitis caused by Aspergillus terreus and the effect of subconjunctival oxiconazole treatment in the animal model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Corneal Ulcer; Disease Models, Animal; Female; Flucytosine; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Morpholines; Rabbits | 1990 |
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.
Topics: Adult; Amphotericin B; Arizona; California; Coccidioidomycosis; Dermatomycoses; Female; Follow-Up Studies; HIV Infections; Humans; Ketoconazole; Leukocyte Count; Liver Diseases; Lung Diseases, Fungal; Lymphatic Diseases; Male; Meningitis; Retrospective Studies; T-Lymphocytes, Helper-Inducer | 1990 |
Effect of antifungal agents on the adherence of Candida albicans to murine gastrointestinal mucosal surfaces.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Bacterial Adhesion; Candida albicans; Gastric Mucosa; Hydrogen-Ion Concentration; Intestinal Mucosa; Itraconazole; Jejunum; Ketoconazole; Mice; Microbial Sensitivity Tests | 1990 |
Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Chromatography, High Pressure Liquid; Granulomatous Disease, Chronic; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Osteomyelitis; Radiography; Trimethoprim, Sulfamethoxazole Drug Combination | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Disease Models, Animal; Drug Administration Schedule; Evaluation Studies as Topic; Female; Fluconazole; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis; Mice; Pharmaceutical Vehicles; Rats; Rats, Inbred Strains; Triazoles | 1990 |
False aneurysm infected by Aspergillus fumigatus: an unusual complication of aortofemoral bypass graft.
Topics: Amphotericin B; Aneurysm, Infected; Antifungal Agents; Aorta, Abdominal; Aspergillosis; Aspergillus fumigatus; Blood Vessel Prosthesis; Femoral Artery; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Middle Aged | 1990 |
Effect of amphotericin B, fluconazole and itraconazole on intracellular Candida albicans and germ tube development in macrophages.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Cells, Cultured; Colony Count, Microbial; Fluconazole; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
A case of fungal keratitis caused by Scopulariopsis brevicaulis: treatment with antifungal agents and penetrating keratoplasty.
Topics: Adult; Amphotericin B; Antifungal Agents; Combined Modality Therapy; Eye Infections, Fungal; Humans; Itraconazole; Keratitis; Keratoplasty, Penetrating; Ketoconazole; Male; Mitosporic Fungi | 1990 |
In vitro activity of saperconazole (R66 905) compared with amphotericin B and itraconazole against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Azoles; Itraconazole; Ketoconazole; Species Specificity | 1990 |
Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Drug Evaluation, Preclinical; Drug Therapy, Combination; Extracellular Space; Female; Itraconazole; Ketoconazole; Macrophages; Mice; Phagocytosis | 1990 |
Endogenous Candida endophthalmitis. Management without intravenous amphotericin B.
Topics: Adult; Aged; Amphotericin B; Candida; Candida albicans; Candidiasis; Endophthalmitis; Eye Infections, Fungal; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Prognosis; Visual Acuity; Vitrectomy; Vitreous Body | 1990 |
Antifungal drugs affect adherence of Candida albicans to acrylic surfaces by changing the zeta-potential of fungal cells.
Topics: Acrylates; Adhesiveness; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Electrophoresis; Ketoconazole; Macrolides; Miconazole; Peptides, Cyclic | 1990 |
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts | 1990 |
Chronic mucocutaneous candidiasis in childhood and complications of non-Candida infection: a report of the Pediatric Immunodeficiency Collaborative Study Group.
Topics: Adolescent; Amphotericin B; Autoimmune Diseases; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Child, Preschool; Endocrine System Diseases; Family; Female; Flucytosine; Humans; Immunoglobulin A; Immunoglobulin G; Incidence; Infant; Infections; Ketoconazole; Lung Diseases; Male; Survival Rate | 1990 |
Drugs for treatment of fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses | 1990 |
Disseminated histoplasmosis in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Actuarial Analysis; Adult; Amphotericin B; Cryptococcosis; Evaluation Studies as Topic; Female; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged; Retrospective Studies; Texas; Time Factors | 1990 |
Prototheca wickerhamii tenosynovitis.
Topics: Amphotericin B; Carpal Tunnel Syndrome; Drainage; Female; Humans; Ketoconazole; Middle Aged; Prototheca; Reoperation; Surgical Wound Infection; Synovectomy; Synovial Membrane; Tenosynovitis | 1990 |
Orthopaedic manifestations of blastomycosis.
Topics: Amphotericin B; Arthritis, Infectious; Blastomycosis; Child; Female; Humans; Ketoconazole; Male; Middle Aged; Osteomyelitis; Radiography; Retrospective Studies | 1990 |
Sinus and nasal manifestations of the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Anti-Bacterial Agents; HIV Seropositivity; Humans; Ketoconazole; Nasopharyngeal Diseases; Opportunistic Infections; Paranasal Sinus Diseases; Rifampin; Therapeutic Irrigation | 1990 |
Cutaneous histoplasmosis in the acquired immune deficiency syndrome--a report of three cases from Trinidad.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Biopsy; Dermatomycoses; Enzyme-Linked Immunosorbent Assay; Female; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged; Staining and Labeling; Trinidad and Tobago | 1988 |
Experience with itraconazole in cryptococcosis and aspergillosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Cryptococcosis; Disease; Heart Transplantation; Humans; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Neoplasms; Opportunistic Infections | 1989 |
Comparison of the efficacies of amphotericin B, fluconazole, and itraconazole against a systemic Candida albicans infection in normal and neutropenic mice.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Half-Life; Itraconazole; Ketoconazole; Male; Mice; Neutropenia; Triazoles | 1989 |
Treatment of disseminated histoplasmosis in hamsters.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Cricetinae; Female; Histoplasma; Histoplasmosis; Itraconazole; Ketoconazole; Liver; Lung; Male; Mesocricetus; Spleen | 1989 |
Effect of methotrexate alone and in combination with antifungal drugs on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Flucytosine; Itraconazole; Ketoconazole; Methotrexate; Microbial Sensitivity Tests; Spores, Fungal; Time Factors | 1989 |
Treatment of experimental zygomycosis in guinea pigs with azoles and with amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Azoles; Fluconazole; Guinea Pigs; Itraconazole; Ketoconazole; Male; Mucormycosis; Rhizopus; Triazoles | 1989 |
Itraconazole vs amphotericin B: in vitro comparative evaluation of the minimal inhibitory concentration (MIC) against clinically isolated yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Cryptococcus neoformans; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1989 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
Fungemia caused by an amphotericin B-resistant isolate of Sporothrix schenckii. Successful treatment with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazole; Ketoconazole; Male; Middle Aged; Sepsis; Sporothrix; Sporotrichosis | 1989 |
AIDS with disseminated histoplasmosis.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged | 1989 |
[Candida meningitis in a human immunodeficiency virus seropositive woman].
Topics: Adult; Amphotericin B; Candidiasis; Female; HIV Seropositivity; Humans; Ketoconazole; Meningitis | 1989 |
Effect of antimicrobial and antineoplastic drugs alone and in combination on the phagocytic and candidacidal function of human polymorphonuclear leucocytes.
Topics: Amphotericin B; Anti-Bacterial Agents; Antineoplastic Agents; Candida albicans; Cefuroxime; Ketoconazole; Methotrexate; Neutrophils; Phagocytosis; Prednisolone; Tobramycin; Vinblastine | 1989 |
Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Female; Flucytosine; Humans; Hyponatremia; Ketoconazole; Male; Meningitis; Middle Aged; Pancytopenia; Prognosis; Recurrence | 1989 |
[Candida fungemia].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Blood; Candida albicans; Candidiasis; Child; Child, Preschool; Cross Infection; Female; Humans; Ketoconazole; Male; Middle Aged; Retrospective Studies | 1989 |
Clinical review: progressive disseminated histoplasmosis in the AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Biopsy; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Lung; Radiography | 1989 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endocarditis; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Rabbits | 1987 |
Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.
Topics: Adult; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Female; Humans; Itraconazole; Ketoconazole; Leukemia, Myeloid, Acute; Lung Diseases, Fungal; Pneumonectomy | 1988 |
Efficacies of four antifungal agents in experimental murine sporotrichosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Drug Evaluation, Preclinical; Itraconazole; Ketoconazole; Mice; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 1988 |
Treatment of experimental sub-acute cryptococcosis in the Wistar rat.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain Diseases; Cryptococcosis; Female; Granuloma, Giant Cell; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Polyethylene Glycols; Rats; Rats, Inbred Strains | 1988 |
Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole.
Topics: Administration, Oral; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Recurrence; Time Factors | 1989 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1985 |
Itraconazole treatment of murine aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; Itraconazole; Ketoconazole; Male; Mice; Mice, Inbred ICR | 1985 |
Inhibition of in vitro HBsAg production by amphotericin B and ketoconazole.
Topics: Amphotericin B; Antigens, Neoplasm; Antiviral Agents; Carcinoma, Hepatocellular; Cell Line; Depression, Chemical; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Hepatitis B; Hepatitis B Surface Antigens; Humans; Ketoconazole; Liver Neoplasms; Neoplasm Proteins; Vidarabine | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
Semiautomated assessment of in vitro activity of potential antileishmanial drugs.
Topics: Aminoquinolines; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Automation; Azure Stains; Drug Evaluation, Preclinical; Formycins; Humans; In Vitro Techniques; Ketoconazole; Leishmania tropica; Macrophages; Pentamidine; Tritium; Uracil | 1985 |
Efficacy of UK-49,858 (fluconazole) against Candida albicans experimental infections in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Fluconazole; Immune Tolerance; Intestinal Diseases; Ketoconazole; Kinetics; Mice; Triazoles | 1985 |
Treatment of murine coccidioidal meningitis with fluconazole (UK 49,858).
Topics: Amphotericin B; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fluconazole; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred ICR; Triazoles | 1986 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
A diffusion chamber technique for testing of antifungal drugs against Sporothrix schenckii in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Female; Itraconazole; Ketoconazole; Mice; Potassium Iodide; Sporothrix; Sporotrichosis; Triazoles | 1986 |
In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils.
Topics: Amphotericin B; Candida albicans; Humans; Itraconazole; Ketoconazole; Neutrophils; Phagocytosis; Spores, Fungal | 1986 |
Treatment of cryptococcal meningitis in mice with fluconazole.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Fluconazole; Ketoconazole; Kinetics; Meningitis; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Rats; Rats, Inbred Strains; Triazoles | 1986 |
Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Culture Techniques; Fluconazole; Histoplasma; Histoplasmosis; Ketoconazole; Male; Mice; Triazoles | 1987 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Brain Diseases; Cryptococcosis; Female; Fluconazole; Ketoconazole; Lung Diseases, Fungal; Mice; Opportunistic Infections; Triazoles | 1987 |
[A case of cryptococcal meningitis successfully treated by ketoconazole and amphotericin B combination therapy].
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Meningitis | 1986 |
Renal aspergilloma--a case illustrating the problems of medical therapy.
Topics: Amphotericin B; Aspergillosis; Female; Flucytosine; Humans; Ketoconazole; Kidney Diseases; Middle Aged; Nephrectomy | 1987 |
Adrenal mass in an immunocompromised man.
Topics: Abscess; Adrenal Gland Diseases; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Diagnosis, Differential; Drainage; Drug Therapy, Combination; Humans; Ketoconazole; Male; Middle Aged; Opportunistic Infections; Rifampin; Sarcoidosis | 1988 |
MIC and fungicidal activity of terbinafine against clinical isolates of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Aspergillus niger; Humans; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1988 |
[Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Clotrimazole; Drug Resistance, Microbial; Female; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Male; Miconazole; Nystatin | 1988 |
The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Amphotericin B; Candida; Candidiasis, Oral; Female; Humans; Ketoconazole; Leukemia; Male; Middle Aged | 1988 |
Esophageal candidiasis.
Topics: Amphotericin B; Autoimmune Diseases; Candidiasis; Esophageal Diseases; Esophagoscopy; Female; Humans; Immune Tolerance; Ketoconazole; Male; Middle Aged; Neoplasms; Prospective Studies | 1988 |
Candida albicans corpora abscess following penile prosthesis placement.
Topics: Abscess; Amphotericin B; Candidiasis; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction; Humans; Ketoconazole; Male; Middle Aged; Penile Diseases; Prostheses and Implants | 1988 |
Antifungal susceptibility testing of Trichosporon beigelii to imidazole compounds.
Topics: Amphotericin B; Clotrimazole; Culture Media; Econazole; Genital Diseases, Male; Hair; Humans; Imidazoles; Ketoconazole; Male; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses; Piedra; Scrotum; Trichosporon | 1988 |
Ketoconazole treatment of coccidioidal meningitis.
Topics: Amphotericin B; Coccidioidomycosis; Drug Therapy, Combination; Humans; Ketoconazole; Leukocyte Count; Meningitis | 1988 |
Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Echinocandins; Flucytosine; Humans; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Temperature; Time Factors | 1988 |
Asian form of disseminated histoplasmosis diagnosed by CT-guided biopsy of the adrenals treated with ketoconazol.
Topics: Adrenal Glands; Aged; Amphotericin B; Biopsy; Histoplasmosis; Humans; Indonesia; Ketoconazole; Male; Netherlands; Tomography, X-Ray Computed | 1988 |
In vitro susceptibility of Cryptococcus neoformans isolates from patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1988 |
[In vitro sensitivity of Aspergillus to terbinafine: comparative study on amphotericin B, 5-fluorocytosine and ketoconazole].
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1988 |
Bilateral Pseudallescheria boydii endophthalmitis in an immunocompromised patient.
Topics: Amphotericin B; Ascomycota; Drug Resistance, Microbial; Endophthalmitis; Humans; Immune Tolerance; Ketoconazole; Kidney Transplantation; Male; Middle Aged; Mycoses; Pseudallescheria | 1988 |
Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Hyperbaric Oxygenation; Ketoconazole; Miconazole; Nystatin; Time Factors | 1987 |
[Chromomycosis].
Topics: Amphotericin B; Chromoblastomycosis; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Mozambique | 1987 |
Imidazole therapy of coccidioidal meningitis in children.
Topics: Administration, Oral; Amphotericin B; Cerebrospinal Fluid Shunts; Child; Child, Preschool; Coccidioidomycosis; Combined Modality Therapy; Female; Humans; Infant; Injections, Intravenous; Injections, Intraventricular; Injections, Spinal; Ketoconazole; Male; Meningitis; Miconazole; Peritoneal Cavity | 1988 |
Drugs for treatment of deep fungal infection.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Ketoconazole; Mycoses; Opportunistic Infections | 1988 |
Emphysematous prostatitis and cystitis secondary to Candida albicans.
Topics: Amphotericin B; Candidiasis; Cystitis; Emphysema; Humans; Ketoconazole; Male; Middle Aged; Prostatitis | 1988 |
Comparative activity in different media of ketoconazole, miconazole and amphotericin B against Candida lusitaniae and sucrose-negative Candida tropicalis.
Topics: Amphotericin B; Candida; Culture Media; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose | 1988 |
Rhinocerebral mucormycosis with cerebral extension successfully treated with adjunctive hyperbaric oxygen therapy.
Topics: Adult; Amphotericin B; Brain Abscess; Brain Diseases; Combined Modality Therapy; Debridement; Female; Humans; Hyperbaric Oxygenation; Ketoconazole; Middle Aged; Mucormycosis; Nose Diseases; Prognosis; Time Factors; Tomography, X-Ray Computed | 1988 |
Evaluation of single-drug and combination antifungal therapy in an experimental model of candidiasis in rabbits with prolonged neutropenia.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cytarabine; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Neutropenia; Rabbits; Rifampin | 1988 |
Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Female; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged | 1988 |
[Role of invasive candidiasis in hospital pathology].
Topics: Adolescent; Adult; Aged; Amphotericin B; Blood; Candidiasis; Child; Child, Preschool; Cross Infection; Female; Hospitals, General; Humans; Infant; Ketoconazole; Male; Middle Aged; Paris; Retrospective Studies; Sepsis | 1987 |
The current status of antimycotics in the treatment of local mycoses.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Antifungal Agents; Benzoates; Dermatomycoses; Drug Combinations; Etretinate; Female; Griseofulvin; Humans; Imidazoles; Ketoconazole; Nystatin; Potassium Permanganate; Resorcinols; Salicylates; Salicylic Acid; Suppositories; Tretinoin; Vagina | 1986 |
Hepatic candidiasis: an increasing problem in immunocompromised patients.
Topics: Adult; Amphotericin B; Biopsy; Candida; Candidiasis; Drug Therapy, Combination; Female; Flucytosine; Humans; Immunologic Deficiency Syndromes; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver; Liver Diseases; Male | 1987 |
Incidence and treatment of fungal infections in neutropenic patients.
Topics: Agranulocytosis; Amphotericin B; Female; Humans; Ketoconazole; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Male; Middle Aged; Mycoses; Neutropenia | 1987 |
Oral ketoconazole and intraocular amphotericin B for treatment of postoperative Candida parapsilosis endophthalmitis.
Topics: Administration, Oral; Aged; Aged, 80 and over; Amphotericin B; Candidiasis; Cataract Extraction; Drug Contamination; Endophthalmitis; Humans; Ketoconazole; Male; Surgical Wound Infection; Therapeutic Irrigation | 1987 |
An outbreak of Candida parapsilosis endophthalmitis: analysis of strains by enzyme profile and antifungal susceptibility.
Topics: Amphotericin B; Candida; Candidiasis; Disease Outbreaks; Drug Contamination; Endophthalmitis; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Postoperative Complications | 1987 |
The place of elective vitrectomy in the management of patients with Candida endophthalmitis.
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Female; Flucytosine; Follow-Up Studies; Humans; Ketoconazole; Male; Visual Acuity; Vitrectomy | 1987 |
Tricuspid valve Candida endocarditis. Successful treatment with valve-sparing debridement and antifungal chemotherapy in a multiorgan transplant recipient.
Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis; Combined Modality Therapy; Debridement; Endocarditis; Female; Humans; Ketoconazole; Kidney Transplantation; Pancreas Transplantation; Time Factors; Tricuspid Valve | 1986 |
The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Topics: Adhesiveness; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cheek; Dose-Response Relationship, Drug; Epithelium; Flucytosine; Humans; In Vitro Techniques; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Time Factors | 1986 |
Feline sporotrichosis.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Female; Humans; Ketoconazole; Male; Potassium Iodide; Sporotrichosis; Zoonoses | 1986 |
Effect of medium composition on results of macrobroth dilution antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Candida; Candida albicans; Cryptococcus neoformans; Culture Media; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Yeasts | 1986 |
Pulmonary eosinophilia in coccidioidal infections.
Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Middle Aged; Pulmonary Eosinophilia | 1987 |
Disseminated histoplasmosis in two patients with chronic mucocutaneous candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Child; Female; Histoplasmosis; Humans; Ketoconazole; Male; Recurrence | 1987 |
Cerebral phaeohyphomycosis.
Topics: Amphotericin B; Brain Abscess; Cladosporium; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Middle Aged; Mycoses | 1987 |
High dose ketoconazole in the treatment of cerebral aspergilloma.
Topics: Adult; Amphotericin B; Aspergillosis; Brain Diseases; Drug Therapy, Combination; Female; Flucytosine; Hong Kong; Humans; Ketoconazole; Tomography, X-Ray Computed | 1987 |
Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods.
Topics: Agar; Amphotericin B; Antifungal Agents; Candida; Flucytosine; Ketoconazole; Microbial Sensitivity Tests | 1987 |
Management of cryptococcosis and toxic epidermal necrolysis in a dog.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Stevens-Johnson Syndrome | 1987 |
Experimental cyclosporine nephrotoxicity: risk of concomitant chemotherapy.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Cyclosporins; Drug Interactions; Gentamicins; Ketoconazole; Kidney; Kidney Diseases; Male; Rats; Rats, Inbred Strains; Risk | 1986 |
Histoplasmosis therapy.
Topics: Amphotericin B; Child; Histoplasmosis; Humans; Ketoconazole; Male | 1986 |
Gastrointestinal dissemination of coccidioidomycosis.
Topics: Adult; Amphotericin B; Chylous Ascites; Coccidioidomycosis; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Recurrence | 1986 |
In vitro evaluation of various antifungal agents alone and in combination by using an automatic turbidimetric system combined with viable count determinations.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1986 |
Orbital mucormycosis with survival.
Topics: Amphotericin B; Humans; Ketoconazole; Male; Middle Aged; Mucormycosis; Orbital Diseases | 1986 |
Cutaneous mucormycosis: a rare cause of leg ulceration.
Topics: Aged; Amphotericin B; Ampicillin; Dermatomycoses; Drug Combinations; Floxacillin; Humans; Ketoconazole; Leg Ulcer; Male; Mucormycosis | 1986 |
[Progress in chemotherapeutic agents--antifungal agents].
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Ketoconazole; Nystatin | 1986 |
Medium for susceptibility testing and yeast phase conversion of Blastomyces dermatitidis.
Topics: Amphotericin B; Blastomyces; Culture Media; Humans; Ketoconazole; Microbial Sensitivity Tests | 1986 |
Coccidioides immitis infections in bones and joints.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Child, Preschool; Coccidioidomycosis; Complement Fixation Tests; Female; Humans; Infant; Joint Diseases; Ketoconazole; Male; Middle Aged; Radiography; Retrospective Studies | 1986 |
Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.
Topics: Amphotericin B; Animals; Candida; Candidiasis; Culture Media; Flucytosine; Humans; Ketoconazole; Mice; Miconazole; Microbial Sensitivity Tests | 1986 |
A further indigenous case of 'North American' blastomycosis from South Africa. Importance of skin lesions in early diagnosis.
Topics: Amphotericin B; Blastomycosis; Humans; Ketoconazole; Male; Middle Aged; South Africa | 1986 |
Histoplasmosis in patients with the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Drug Therapy, Combination; Ethnicity; Female; Histoplasma; Histoplasmosis; Humans; Ketoconazole; Male; Middle Aged | 1986 |
Coccidioidomycosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Arizona; Coccidioidomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies | 1987 |
[Aspergillus infection and chronic septic granulomatosis].
Topics: Adolescent; Amphotericin B; Aspergillosis; Child; Child, Preschool; Female; Granulomatous Disease, Chronic; Humans; Infant; Infant, Newborn; Ketoconazole; Lung Diseases, Fungal; Male | 1985 |
In vitro sensitivity of Malassezia spp. to various antimycotics.
Topics: Amphotericin B; Animals; Antifungal Agents; Clotrimazole; Dog Diseases; Dogs; Econazole; Humans; Ketoconazole; Malassezia; Miconazole; Microbial Sensitivity Tests; Nystatin; Otitis; Tinea Versicolor | 1985 |
Candida esophagitis in two children with acute leukemia: successful therapy with ketoconazole.
Topics: Amphotericin B; Candidiasis, Cutaneous; Candidiasis, Oral; Child; Esophagitis; Female; Humans; Ketoconazole; Leukemia, Lymphoid; Male; Nystatin; Thrombocytopenia | 1985 |
Histoplasmosis in the acquired immune deficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candidiasis; Female; Herpes Simplex; Histoplasmosis; Homosexuality; Humans; Ketoconazole; Male; Mycobacterium avium; Mycobacterium Infections; Pneumonia, Pneumocystis; Tuberculosis | 1985 |
Candidal endophthalmitis in Glaswegian heroin addicts: report of an epidemic.
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Disease Outbreaks; Endophthalmitis; Female; Fundus Oculi; Heroin Dependence; Humans; Ketoconazole; Male; Scotland | 1985 |
[Treatment Candida albicans endophthalmitis with ketoconazole].
Topics: Amphotericin B; Candidiasis; Endophthalmitis; Flucytosine; Humans; Ketoconazole | 1985 |
The effectiveness, in vitro, of miconazole and ketoconazole combined with tissue conditioners in inhibiting the growth of Candida albicans.
Topics: Acrylic Resins; Amphotericin B; Candida albicans; Fentanyl; Isothiocyanates; Ketoconazole; Methylmethacrylates; Miconazole; Nystatin; Phthalic Acids; Tissue Conditioning, Dental | 1985 |
Cutaneous, ocular, and osteoarticular candidiasis in heroin addicts: new clinical and therapeutic aspects in 38 patients.
Topics: Adult; Aged; Amphotericin B; Bone Diseases; Candida albicans; Candidiasis; Candidiasis, Cutaneous; Eye Diseases; Female; Flucytosine; France; Heroin Dependence; Humans; Joint Diseases; Ketoconazole; Male; Middle Aged; Osteoarthritis; Scalp; Syndrome | 1985 |
Combined ketoconazole and amphotericin B treatment of acute disseminated histoplasmosis in a renal allograft recipient.
Topics: Acute Disease; Adult; Amphotericin B; Drug Combinations; Follow-Up Studies; Histoplasmosis; Humans; Immunosuppression Therapy; Ketoconazole; Kidney Transplantation; Male; Postoperative Complications | 1985 |
Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
Topics: Adenosine Triphosphate; Amphotericin B; Antifungal Agents; Candida albicans; Depression, Chemical; Imidazoles; Ketoconazole; Miconazole; Naphthalenes; Terbinafine | 1985 |
Ketoconazole and the antifungals.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Chronic Mucocutaneous; Humans; Ketoconazole; Mycoses | 1985 |
[Systemic candidiasis].
Topics: Amphotericin B; Candidiasis; Combined Modality Therapy; Female; Gestational Age; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Male; Parenteral Nutrition; Respiration, Artificial | 1985 |
Ketoconazole: clinical pharmacology and therapeutic recommendations.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Dog Diseases; Dogs; Drug Interactions; Female; Humans; Ketoconazole; Leishmania; Mycoses; Pregnancy; Staphylococcus aureus | 1986 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1986 |
Blastomycosis in a ferret.
Topics: Amphotericin B; Animals; Blastomycosis; Carnivora; Female; Ferrets; Ketoconazole | 1985 |
Study of current and new drugs in a murine model of acute paracoccidioidomycosis.
Topics: Amphotericin B; Animals; Imidazoles; Ketoconazole; Lung; Male; Mice; Mice, Inbred BALB C; Paracoccidioides; Paracoccidioidomycosis; Spleen; Triazoles | 1985 |
Amphotericin B resistance in Candida.
Topics: Amphotericin B; Candidiasis; Drug Interactions; Drug Resistance, Microbial; Humans; Ketoconazole; Miconazole | 1985 |
Paracoccidioidomycosis: a comparative study of the evolutionary serologic, clinical and radiologic results for patients treated with ketoconazole or amphotericin B plus sulfonamides.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ketoconazole; Male; Middle Aged; Paracoccidioidomycosis; Sulfadimethoxine; Sulfadoxine; Sulfonamides | 1985 |
Intraocular penetration of systemically administered antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Drug Contamination; Eye; Flucytosine; Humans; Ketoconazole; Orbital Diseases; Postoperative Complications; Therapeutic Irrigation | 1985 |
Unsuccessful treatment of disseminated protothecosis in a dog.
Topics: Amphotericin B; Animals; Chloramphenicol; Dog Diseases; Dogs; Eye Diseases; Gentamicins; Infections; Ketoconazole; Prototheca | 1985 |
The effect of ketoconazole on amphotericin B in a model of disseminated aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Disease Models, Animal; Female; Humans; In Vitro Techniques; Ketoconazole; Liver Diseases; Mice; Neutropenia; Premedication | 1985 |
Imidazoles, ketoconazole, amphotericin B, and Candida guilliermondii.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Microbial; Imidazoles; Ketoconazole | 1985 |
Activities of the modified polyene N-D-ornithyl amphotericin methyl ester and the azoles ICI 153066, Bay n 7133, and Bay l 9139 compared with those of amphotericin B and ketoconazole in the therapy of experimental blastomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Imidazoles; Ketoconazole; Male; Mice; Mice, Inbred BALB C; Time Factors; Triazoles | 1985 |
Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature.
Topics: Adult; Amphotericin B; Antibodies, Fungal; Coccidioidomycosis; Complement Fixation Tests; Erythema; Furosemide; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Pulmonary Edema; Respiratory Insufficiency | 1985 |
Fungal peritonitis in patients on peritoneal dialysis: incidence, clinical features and prognosis.
Topics: Adult; Aged; Amphotericin B; Catheters, Indwelling; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Male; Miconazole; Middle Aged; Mycoses; Peritoneal Dialysis; Peritonitis; Prognosis | 1985 |
Statistical analysis for experimental models of ocular disease: continuous response measures.
Topics: Amphotericin B; Analysis of Variance; Animals; Candidiasis; Eye Diseases; In Vitro Techniques; Keratitis; Ketoconazole; Ophthalmology; Rabbits; Statistics as Topic | 1985 |
Disseminated candidiasis with extensive folliculitis in abusers of brown Iranian heroin.
Topics: Adult; Amphotericin B; Candidiasis; Conjunctivitis; Female; Flucytosine; Folliculitis; Heroin; Humans; Iran; Ketoconazole; Male; Substance-Related Disorders | 1985 |
Rhinocerebral mucormycosis in a diabetic ketoacidotic patient.
Topics: Acidosis; Amphotericin B; Diabetes Complications; Diabetes Mellitus; Humans; Ketoconazole; Ketone Bodies; Male; Middle Aged; Mucormycosis; Paranasal Sinus Diseases; Tomography, X-Ray Computed | 1985 |
Simplified bioassay method for measurement of flucytosine or ketoconazole.
Topics: Amphotericin B; Biological Assay; Candida; Cytosine; Flucytosine; Humans; Ketoconazole | 1985 |
Wangiella dermatitidis endocarditis in an intravenous drug user.
Topics: Adult; Amphotericin B; Aortic Valve; Drug Therapy, Combination; Endocarditis; Heart Valve Diseases; Heroin Dependence; Humans; Ketoconazole; Male; Mitosporic Fungi; Mycoses; Recurrence; Reoperation; Rifampin | 1985 |
Acremonium kiliense osteomyelitis of the calvarium.
Topics: Adult; Amphotericin B; Clindamycin; Humans; Ketoconazole; Male; Mitosporic Fungi; Mycoses; Osteomyelitis; Skull; Tomography, X-Ray Computed | 1985 |
[North American blastomycosis].
Topics: Adult; Amphotericin B; Biopsy; Blastomyces; Blastomycosis; Combined Modality Therapy; Diagnosis, Differential; Humans; Ketoconazole; Male; Skin | 1985 |
Cryptococcal meningitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Cryptococcosis; Flucytosine; Follow-Up Studies; Garlic; Humans; Ketoconazole; Meningitis; Miconazole; Middle Aged; Plant Extracts; Plants, Medicinal | 1985 |
Trichosporon infection in a cat.
Topics: Amphotericin B; Animals; Cat Diseases; Cats; Chemical and Drug Induced Liver Injury; Humans; Ketoconazole; Mycoses; Nose Diseases; Trichosporon | 1985 |
[Treatment of Candida mycosis--new aspects?].
Topics: Amphotericin B; Antifungal Agents; Candidiasis, Cutaneous; Humans; Ketoconazole | 1985 |
Systemic candidiasis in premature infants experience with drug treatment.
Topics: Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Flucytosine; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Miconazole | 1985 |
Isolated Candida arthritis: report of a case and definition of a distinct clinical syndrome.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Drug Therapy, Combination; Flucytosine; Humans; Injections, Intra-Articular; Ketoconazole; Knee Joint; Male; Middle Aged | 1985 |
Epidemic postsurgical Candida parapsilosis endophthalmitis. Clinical findings and management of 15 consecutive cases.
Topics: Aged; Amphotericin B; Candidiasis; Cataract Extraction; Eye Diseases; Female; Flucytosine; Humans; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Therapeutic Irrigation | 1985 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Amphotericin B; Humans; Ketoconazole; Leukemia; Mycoses | 1984 |
[Cryptococcus neoformans meningoencephalitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Male; Meningoencephalitis; Miconazole; Prognosis | 1984 |
The effect of ketoconazole and a combination of rifampicin/amphotericin B on cutaneous leishmaniasis in laboratory mice.
Topics: Amphotericin B; Animals; Drug Therapy, Combination; Ketoconazole; Leishmaniasis; Male; Mice; Mice, Inbred BALB C; Rifampin | 1984 |
In vitro susceptibility testing of Naegleria fowleri to ketoconazole, BAYn7133, and allopurinol riboside.
Topics: Allopurinol; Amoeba; Amphotericin B; Animals; Antiprotozoal Agents; Ketoconazole; Microbial Sensitivity Tests; Ribonucleosides; Triazoles | 1984 |
Case report: blastomycosis causing sciatic neuritis.
Topics: Adult; Amphotericin B; Blastomyces; Blastomycosis; Female; Humans; Ilium; Ketoconazole; Neuritis; Sciatic Nerve | 1984 |
Drug therapy of systemic fungal infections, Part I.
Topics: Amphotericin B; Biological Availability; Humans; Ketoconazole; Kinetics; Mycoses | 1984 |
Hematogenous histoplasmosis in the immunocompromised child.
Topics: Adolescent; Amphotericin B; Antineoplastic Agents; Child; Child, Preschool; Female; Histoplasmosis; Humans; Immunosuppression Therapy; Infant; Ketoconazole; Male; Risk | 1984 |
Broth dilution and disc diffusion methods in the susceptibility testing of pathogenic Candida albicans against four antimycotics.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Chlorhexidine; Clotrimazole; Drug Resistance, Microbial; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth; Stomatitis | 1984 |
Candidiasis in cancer patients.
Topics: Amphotericin B; Antibodies, Fungal; Candidiasis; Cephalosporins; Humans; Ketoconazole; Leukemia; Miconazole; Neoplasms; Pneumonia | 1984 |
Systemic candidiasis in cancer patients.
Topics: Acute Disease; Amphotericin B; Bacterial Infections; Bacteriological Techniques; Candida; Candidiasis; Cytomegalovirus Infections; Humans; Ketoconazole; Leukemia; Lymphoma; Miconazole; Mycoses; Neoplasms; Neutropenia | 1984 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles | 1984 |
Phialophora parasitica, an emerging pathogen.
Topics: Amphotericin B; Chloramphenicol; Cycloheximide; Fluorouracil; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mycoses; Phialophora | 1984 |
Effective systemic antifungal agents.
Topics: Administration, Oral; Amphotericin B; Cytosine; Drug Evaluation; Drug Resistance, Microbial; Flucytosine; Half-Life; Humans; Infusions, Parenteral; Ketoconazole; Miconazole; Mycoses | 1984 |
Candidiasis.
Topics: Amphotericin B; Candidiasis; Child, Preschool; Female; Humans; Infant; Ketoconazole; Male | 1984 |
[Cutaneous mucormycosis in a diabetic woman. Diagnostic and therapeutic problems].
Topics: Amphotericin B; Bandages; Casts, Surgical; Dermatomycoses; Diabetes Mellitus, Type 1; Female; Humans; Ketoconazole; Middle Aged; Mucormycosis | 1984 |
[Coccidioidomycosis. Report of a case. Review of the literature].
Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Drug Therapy, Combination; Humans; Ketoconazole; Male; Skin Tests; Transfer Factor | 1984 |
Oral ketoconazole and amphotericin B for the prevention of yeast colonization in patients with acute leukaemia.
Topics: Acute Disease; Amphotericin B; Humans; Ketoconazole; Leukemia; Mycoses | 1984 |
Relapse of Candida parapsilosis endocarditis after long-term suppression with flucytosin: retreatment with valve replacement and ketoconazole.
Topics: Adult; Amphotericin B; Candidiasis; Cytosine; Drug Therapy, Combination; Endocarditis; Female; Flucytosine; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitral Valve; Piperazines; Recurrence | 1980 |
Ocular toxicity of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Cornea; Eye; Flucytosine; Imidazoles; Iritis; Ketoconazole; Miconazole; Piperazines; Rabbits | 1981 |
[Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cytosine; Drug Interactions; Econazole; Flucytosine; Imidazoles; Ketoconazole; Nystatin; Piperazines; Saccharomyces cerevisiae | 1981 |
Chemotherapy of experimental endogenous Candida albicans endophthalmitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Therapy, Combination; Endophthalmitis; Fluorescein Angiography; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines; Rabbits; Retinitis; Time Factors | 1980 |
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid.
Topics: Amphotericin B; Antifungal Agents; Biological Assay; Candida; Coccidioides; Humans; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1981 |
Imidazole and polyene activity against chloroquine-resistant Plasmodium falciparum.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimalarials; Drug Resistance; Imidazoles; In Vitro Techniques; Ketoconazole; Miconazole; Piperazines; Plasmodium falciparum | 1981 |
Endogenous Candida albicans endophthalmitis in the rabbit. Chemotherapy for systemic effect.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Endophthalmitis; Imidazoles; Injections, Intravenous; Ketoconazole; Male; Piperazines; Rabbits | 1981 |
In vitro susceptibility of antimony-resistant Leishmania to alternative drugs.
Topics: Amphotericin B; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Antimony; Formycins; Humans; Imidazoles; Ketoconazole; Leishmaniasis; Pentamidine; Piperazines | 1982 |
Ketoconazole, amphotericin B, and amphotericin B methyl ester: comparative in vitro and in vivo toxicological effects on neutrophil function.
Topics: Amphotericin B; Antifungal Agents; Chemotaxis, Leukocyte; Humans; Imidazoles; In Vitro Techniques; Ketoconazole; Leukocytes; Neutrophils; Phagocytosis; Piperazines; Staphylococcus aureus | 1981 |
Susceptibility of zygomycetes to amphotericin B, miconazole, and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines | 1981 |
Conditions associated with relapse of amphotericin B-treated disseminated histoplasmosis.
Topics: Aged; Amphotericin B; Antifungal Agents; Endocarditis; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Leukemia, Lymphoid; Lymphoma, Non-Hodgkin; Male; Middle Aged; Piperazines; Recurrence; Retrospective Studies; Time Factors | 1982 |
Drugs for treatments of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
Therapy of superficial fungal infection.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Candidiasis; Candidiasis, Oral; Dermatomycoses; Flucytosine; Griseofulvin; Humans; Imidazoles; Injections, Intravenous; Ketoconazole; Miconazole; Piperazines; Tinea; Tinea Versicolor | 1982 |
Antifungal action of amphotericin B in combination with other polyene or imidazole antibiotics.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida albicans; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Filipin; Humans; Imidazoles; Ketoconazole; Lucensomycin; Miconazole; Nystatin; Piperazines; Serum Albumin; Time Factors | 1982 |
Treatment of experimental cryptococcal meningitis with amphotericin B, 5-fluorocytosine, and ketoconazole.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Meningitis; Piperazines; Rabbits | 1982 |
Histoplasmosis in Huntsville, Alabama.
Topics: Acute Disease; Adolescent; Adult; Aged; Alabama; Amphotericin B; Bone Diseases; Chronic Disease; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Male; Mediastinal Diseases; Middle Aged; Pericarditis; Piperazines | 1982 |
Susceptibility of dermatiaceous fungi to amphotericin B, miconazole, ketoconazole, flucytosine and rifampin alone and in combination.
Topics: Amphotericin B; Antifungal Agents; Cladosporium; Drug Synergism; Flucytosine; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Piperazines; Rifampin | 1982 |
Cutaneous phaeohyphomycosis of the sole caused by Exophiala jeanselmei and its susceptibility to amphotericin B, 5-FC and ketoconazole.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Drug Resistance, Microbial; Female; Flucytosine; Foot Dermatoses; Humans; Imidazoles; Ketoconazole; Middle Aged; Mitosporic Fungi; Piperazines | 1982 |
Histoplasma infection of abdominal aortic aneurysms.
Topics: Adult; Aged; Amphotericin B; Aorta, Abdominal; Aortic Aneurysm; Arteriosclerosis; Female; Histoplasmosis; Humans; Imidazoles; Ketoconazole; Male; Middle Aged; Piperazines | 1983 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Combination; Humans; Imidazoles; Ketoconazole; Lung Diseases, Fungal; Miconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Neutropenia; Piperazines | 1983 |
Interactions among amphotericin B, 5-fluorocytosine, ketoconazole, and miconazole against pathogenic fungi in vitro.
Topics: Amphotericin B; Antifungal Agents; Cytosine; Drug Synergism; Flucytosine; Fungi; Imidazoles; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Piperazines | 1982 |
A comparison of the effects of several antifungal imidazole derivatives and polyenes on Candida albicans: an ultrastructural study by scanning electron microscopy.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Cell Membrane; Cell Wall; Clotrimazole; Econazole; Imidazoles; Ketoconazole; Miconazole; Microscopy, Electron, Scanning; Nystatin; Piperazines | 1982 |
High-dose ketoconazole for treatment of fungal infections of the central nervous system.
Topics: Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Coccidioidomycosis; Drug Therapy, Combination; Humans; Imidazoles; Ketoconazole; Piperazines | 1983 |
Combination therapy of experimental candidiasis, cryptococcosis and aspergillosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Synergism; Drug Therapy, Combination; Flucytosine; Imidazoles; Ketoconazole; Male; Mice; Piperazines | 1982 |
[First human case of Drechslera longirostrata mycosis. Spondylodiscitis complicating prosthesis endocarditis. Treatment with combined ketoconazole and amphotericin B].
Topics: Adult; Amphotericin B; Antifungal Agents; Endocarditis; Female; Heart Valve Prosthesis; Humans; Imidazoles; Ketoconazole; Mitosporic Fungi; Mycoses; Piperazines; Postoperative Complications; Spondylitis | 1982 |
Toxicity of amphotericin B, miconazole, and ketoconazole to human granulocyte progenitor cells in vitro.
Topics: Amphotericin B; Antifungal Agents; Cells, Cultured; Dose-Response Relationship, Drug; Granulocytes; Hematopoietic Stem Cells; Humans; Imidazoles; Ketoconazole; Miconazole; Piperazines | 1983 |
Effect of ketoconazole on the fungicidal action of amphotericin B in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Interactions; Ergosterol; Imidazoles; Ketoconazole; Piperazines | 1983 |
Candida peritonitis in children on continuous ambulatory peritoneal dialysis.
Topics: Amphotericin B; Candidiasis; Catheterization; Child, Preschool; Female; Humans; Imidazoles; Infant; Ketoconazole; Male; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Piperazines | 1982 |
Antimicrobial treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1983 |
Therapy of fungal infections.
Topics: Amphotericin B; Animals; Clotrimazole; Dogs; Humans; Imidazoles; Ketoconazole; Miconazole; Mycoses; Piperazines | 1982 |
Activity of two polyene and two imidazole antimicrobics on Candida albicans in human fibrin clots.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Fibrin; Humans; Imidazoles; Ketoconazole; Miconazole; Piperazines; Polyenes | 1983 |
Successful treatment of spinal arachnoiditis due to coccidioidomycosis. Case report.
Topics: Adult; Amphotericin B; Arachnoiditis; Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Male; Piperazines; Spinal Cord Diseases | 1983 |
Treatment of systemic mycoses in dogs.
Topics: Amphotericin B; Animals; Antifungal Agents; Dog Diseases; Dogs; Drug Therapy, Combination; Imidazoles; Ketoconazole; Mycoses; Piperazines | 1983 |
Clinical and laboratory features of disseminated histoplasmosis during two large urban outbreaks.
Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Disease Outbreaks; Histoplasmosis; Humans; Immune Tolerance; Indiana; Ketoconazole; Middle Aged; Radiography; Urban Population | 1983 |
Failure of ketoconazole in two patients with blastomycosis.
Topics: Adolescent; Amphotericin B; Blastomycosis; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male | 1983 |
Treatment of experimental murine aspergillosis with BAY n7133.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Ketoconazole; Lung; Male; Mice; Mice, Inbred BALB C; Triazoles | 1983 |
Fine-structural alterations in Leishmania tropica within human macrophages exposed to antileishmanial drugs in vitro.
Topics: Aminoquinolines; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Membrane; Formycins; Humans; Intracellular Membranes; Ketoconazole; Leishmania; Macrophages; Organoids; Pentamidine | 1983 |
Novel synergism of two antifungal agents, copiamycin and imidazole.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Drug Synergism; Fungi; Imidazoles; Ketoconazole; Lactones; Mitochondrial Swelling | 1983 |
Comparison of ketoconazole and amphotericin B in interference with thymidine uptake by and blastogenesis of lymphocytes stimulated with Histoplasma capsulatum antigens.
Topics: Amphotericin B; Antigens, Fungal; Cholesterol; Histoplasma; Humans; In Vitro Techniques; Ketoconazole; Lymphocyte Activation; Thymidine | 1983 |
[Coccidioidomycosis in soldiers of the federal armed forces].
Topics: Adrenal Cortex Hormones; Adult; Amphotericin B; Coccidioidin; Coccidioidomycosis; Diagnosis, Differential; Germany, West; Humans; Ketoconazole; Lung; Male; Military Medicine; Sarcoidosis; Skin Tests; Transfer Factor; Tuberculosis, Pulmonary; United States | 1983 |
Effect of ketoconazole and amphotericin B on encapsulated and non-encapsulated strains of Cryptococcus neoformans.
Topics: Amphotericin B; Cryptococcus; Cryptococcus neoformans; Culture Media; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 1983 |
Hematogenous Candida spondylitis. A case report.
Topics: Amphotericin B; Candidiasis; Clindamycin; Drug Therapy, Combination; Female; Flucytosine; Humans; Ketoconazole; Lumbar Vertebrae; Middle Aged; Osteomyelitis; Spondylitis | 1984 |
Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
Topics: Adrenal Cortex Hormones; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Flucytosine; Keratitis; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Drugs for treatment of systemic fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Ketoconazole; Miconazole; Mycoses | 1984 |
Disseminated sporotrichosis with Sporothrix schenckii fungemia.
Topics: Amphotericin B; Female; Humans; Ketoconazole; Middle Aged; Sepsis; Sporothrix; Sporotrichosis | 1984 |
In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
Topics: Amphotericin B; Candida; Culture Media; Cytosine; Drug Synergism; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Sucrose | 1984 |
Combination of oral flucytosine and ketoconazole as therapy for experimental cryptococcal meningitis.
Topics: Amphotericin B; Animals; Cryptococcosis; Cryptococcus neoformans; Cytosine; Drug Synergism; Drug Therapy, Combination; Female; Flucytosine; Ketoconazole; Male; Meningitis; Mice; Mice, Inbred BALB C | 1984 |
Treatment of murine pulmonary cryptococcosis with ketoconazole and amphotericin B.
Topics: Amphotericin B; Animals; Cryptococcosis; Drug Therapy, Combination; Immunosuppression Therapy; Ketoconazole; Lung Diseases, Fungal; Male; Mice | 1984 |
In vitro susceptibilities of human and wild-type isolates of Basidiobolus and Conidiobolus species.
Topics: Amphotericin B; Antifungal Agents; Culture Media; Flucytosine; Fungi; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Potassium Iodide | 1984 |
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles | 1984 |
Influence of the corneal epithelium on the efficacy of topical antifungal agents.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candidiasis; Cornea; Corneal Diseases; Econazole; Epithelium; Flucytosine; Ketoconazole; Miconazole; Natamycin; Rabbits | 1984 |
Treatment of canine blastomycosis with amphotericin B and ketoconazole.
Topics: Amphotericin B; Animals; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Ketoconazole; Kidney Diseases; Lung Diseases, Fungal; Male; Mannitol; Prognosis | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
Systemic infection by Rhodotorula spp. in the immunocompromised host.
Topics: Adult; Amphotericin B; Bone Marrow; Flucytosine; Humans; Ketoconazole; Leukemia, Myeloid, Acute; Liver Abscess; Male; Mitosporic Fungi; Mycoses; Rhodotorula | 1984 |
[Familial chronic mucocutaneous candidiasis. Study of 2 families].
Topics: Adolescent; Adult; Amphotericin B; Candidiasis; Candidiasis, Chronic Mucocutaneous; Consanguinity; Female; Humans; Ketoconazole; Male; Nystatin; Pedigree | 1984 |
Defining conditions for microbroth antifungal susceptibility tests: influence of RPMI and RPMI-2% glucose on the selection of endpoint criteria.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Culture Media; Flucytosine; Glucose; Ketoconazole; Microbial Sensitivity Tests; Nephelometry and Turbidimetry | 1995 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antiprotozoal Agents; Antiviral Agents; Atovaquone; Candidiasis, Oral; Clindamycin; Clotrimazole; Cryptosporidiosis; Cytomegalovirus Infections; Dapsone; Didanosine; Drug Combinations; Drug Therapy, Combination; Fluconazole; Flucytosine; Folic Acid Antagonists; Foscarnet; Glucuronates; Herpes Simplex; Herpes Zoster; Humans; Isoniazid; Itraconazole; Ketoconazole; Lamivudine; Mycobacterium avium-intracellulare Infection; Naphthoquinones; Nystatin; Pentamidine; Pneumocystis Infections; Pneumonia, Pneumocystis; Prednisone; Primaquine; Reverse Transcriptase Inhibitors; Stavudine; Syphilis; Toxoplasmosis; Trimetrexate; Tuberculosis; Zalcitabine; Zidovudine | 1995 |
Oral histoplasmosis in HIV-infected patients. A report of two cases.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Histoplasmosis; HIV Infections; Humans; Ketoconazole; Male; Mouth Diseases | 1995 |
[Post-antibiotic effect and post-exposure polyene antagonism of azole antimycotics in Candida albicans: dependency on lipophilia].
Topics: Amphotericin B; Candida albicans; Drug Interactions; Fluconazole; Itraconazole; Ketoconazole; Lipids; Miconazole; Microbial Sensitivity Tests; Structure-Activity Relationship | 1995 |
Oral histoplasmosis masquerading as an invasive carcinoma.
Topics: Aged; Amphotericin B; Chronic Disease; Diagnosis, Differential; Female; Histoplasmosis; Humans; Ketoconazole; Maxillary Diseases; Mouth Diseases; Mouth Neoplasms; Ulcer | 1995 |
Bronchoscopic findings in a case of bronchopulmonary histoplasmosis.
Topics: Amphotericin B; Biopsy; Bronchoscopy; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Prednisolone; Respiratory Insufficiency | 1995 |
Increased resistance to antifungal antibiotics of Candida spp. adhered to silicone.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Cell Adhesion; Drug Resistance, Microbial; Fluconazole; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Miconazole; Silicones; Urinary Catheterization | 1995 |
Pulmonary penicillosis marneffei: report of the first imported case in Canada.
Topics: Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Canada; Emigration and Immigration; Female; Humans; Immunodiffusion; Ketoconazole; Lung Diseases, Fungal; Microbial Sensitivity Tests; Middle Aged; Penicillium; Thailand | 1994 |
Blastomycosis: pulmonary and pleural manifestations.
Topics: Adult; Amphotericin B; Blastomycosis; Child; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Pleural Diseases; Pleural Effusion; Prognosis; Radiography | 1995 |
A comparison of susceptibility to five antifungal agents of yeast cultures from burn patients.
Topics: Amphotericin B; Antifungal Agents; Burns; Candida; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Trichosporon; Yeasts | 1995 |
Adaptation of Aspergillus niger to several antifungal agents.
Topics: Adaptation, Physiological; Amphotericin B; Antifungal Agents; Aspergillus niger; Ketoconazole; Miconazole; Spores, Fungal; Time Factors | 1994 |
The postantibiotic effect of antifungal agents against common pathogenic yeasts.
Topics: Amphotericin B; Candida; Cryptococcus neoformans; Flucytosine; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 1994 |
Comparison of broth dilution and semisolid agar dilution for in vitro susceptibility testing of Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Blood; Cerebrospinal Fluid; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Skin | 1994 |
Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit.
Topics: Amphotericin B; Burn Units; Burns; Candida; Candidiasis; Case-Control Studies; Cross Infection; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Retrospective Studies | 1994 |
Effect of ketoconazole on lethal action of amphotericin B on Leishmania mexicana promastigotes.
Topics: Amphotericin B; Animals; Cell Membrane; Diphenylhexatriene; Ergosterol; Fluorescent Dyes; Ketoconazole; Kinetics; Leishmania mexicana; Nitrates; Potassium Compounds; Spectrometry, Fluorescence; Sterols; Temperature | 1994 |
Blastomycosis of the paranasal sinuses.
Topics: Adult; Amphotericin B; Biopsy; Blastomycosis; Bronchoscopy; Combined Modality Therapy; Debridement; Female; Humans; Ketoconazole; Paranasal Sinus Diseases; Prognosis; Sputum; Tomography, X-Ray Computed | 1994 |
Use of antifungal therapy in hospitalized patients. I. Results prior to the marketing of fluconazole.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Drug Utilization; Hospitals; Humans; Ketoconazole; Mycoses; Nystatin; Prospective Studies; Risk Factors; United States | 1994 |
Neonatal renal candidiasis.
Topics: Amphotericin B; Candidiasis; Diagnostic Imaging; Drug Therapy, Combination; Fluconazole; Humans; Infant; Ketoconazole; Male; Pyelonephritis; Ureteral Obstruction | 1994 |
Severe candidal infections in neutropenic patients.
Topics: Amphotericin B; Candidiasis; Fluconazole; Humans; Itraconazole; Ketoconazole; Neutropenia | 1993 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1994 |
Pulmonary sporotrichosis treated with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Middle Aged; Potassium Iodide; Sporotrichosis | 1993 |
Asymptomatic amniotic fluid invasion with Candida albicans in preterm premature rupture of membranes. Implications for obstetric and neonatal management.
Topics: Adult; Amniotic Fluid; Amphotericin B; Candida albicans; Candidiasis; Chorioamnionitis; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Infant, Premature, Diseases; Ketoconazole; Male; Mediastinal Emphysema; Pneumonia; Pregnancy | 1993 |
Efficacy of ganciclovir in combination with other antimicrobial agents against cytomegalovirus in vitro and in vivo.
Topics: Amphotericin B; Animals; Antifungal Agents; Antiviral Agents; Cells, Cultured; Cytomegalovirus Infections; Dapsone; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Ganciclovir; Humans; Ketoconazole; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Species Specificity; Sulfamethoxazole; Survival Analysis; Trimethoprim; Viral Plaque Assay | 1993 |
Renal aspergilloma in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Ketoconazole; Kidney Diseases | 1993 |
Histoplasmosis in the acquired immunodeficiency syndrome (AIDS): treatment with itraconazole and fluconazole.
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Amphotericin B; Antifungal Agents; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Middle Aged; Retrospective Studies; Treatment Outcome | 1993 |
[Strategy for examination and therapy of mycotic keratitis].
Topics: Acremonium; Administration, Oral; Adolescent; Amphotericin B; Antifungal Agents; Contact Lenses; Drug Therapy, Combination; Female; Fluconazole; Humans; Itraconazole; Keratitis; Ketoconazole; Mycoses; Ophthalmic Solutions; Therapeutic Irrigation | 1993 |
Combined anti-fungal therapy and surgical resection as treatment of disseminated aspergillosis of the lung and brain following BMT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Child; Female; Humans; Itraconazole; Ketoconazole; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tomography, X-Ray Computed | 1993 |
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus; Bronchoalveolar Lavage Fluid; Combined Modality Therapy; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Medical History Taking; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Treatment Failure | 1993 |
Treatment of cryptococcal meningitis with short-course amphotericin B and flucytosine, followed by itraconazole.
Topics: Adult; Amphotericin B; Antifungal Agents; Female; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Meningitis, Cryptococcal; Middle Aged | 1993 |
Pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; Ketoconazole; Mycoses; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis | 1993 |
Leishmaniasis: some recent developments in chemotherapy.
Topics: Allopurinol; Amphotericin B; Antiprotozoal Agents; Humans; Ketoconazole; Leishmaniasis; Paromomycin | 1993 |
Comparative effects of antifungal agents on zidovudine glucuronidation by human liver microsomes.
Topics: Amphotericin B; Antifungal Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Fluconazole; Flucytosine; Glucuronates; Humans; Itraconazole; Ketoconazole; Miconazole; Microsomes, Liver; Zidovudine | 1995 |
Systemic antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Mycoses | 1996 |
[Multiple bone lesions of a type of disseminated African histoplasmosis in a Togolese immunocompetent child].
Topics: Acromion; Amphotericin B; Antifungal Agents; Child; Clavicle; Histoplasmosis; Humans; Immunocompetence; Ketoconazole; Osteomyelitis; Radiography; Ribs; Tibia; Togo | 1995 |
Multisite reproducibility of the Etest MIC method for antifungal susceptibility testing of yeast isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Quality Control; Reproducibility of Results | 1996 |
Ocular blastomycosis in dogs: 73 cases, 108 eyes (1985-1993).
Topics: Amphotericin B; Animals; Antifungal Agents; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Eye; Eye Infections, Fungal; Female; Ketoconazole; Male; Prognosis; Retrospective Studies; Treatment Outcome | 1996 |
[Clinical fluconazole and itraconazole resistance of oro-gastrointestinal candidiasis in a patient with AIDS].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Drug Resistance, Multiple; Drug Therapy, Combination; Fluconazole; Flucytosine; Gastrointestinal Diseases; Humans; Ketoconazole; Male; Microbial Sensitivity Tests | 1996 |
Diabetes mellitus, fever, proptosis, and rapid loss of vision.
Topics: Amphotericin B; Antifungal Agents; Child; Diabetes Complications; Humans; Ketoconazole; Male; Mucormycosis; Orbital Diseases | 1996 |
A disc plate assay for characterization of the effect of interaction between polyenes and azoles on growth of Candida albicans CA12.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Drug Antagonism; Fluconazole; Ketoconazole; Microbial Sensitivity Tests | 1996 |
[Role of fungi belonging to the genus Candida in the etiology of nonspecific pulmonary diseases].
Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Antifungal Agents; Candicidin; Candida; Humans; Ketoconazole; Lung Diseases, Fungal; Microbial Sensitivity Tests; Middle Aged; Nystatin; Retrospective Studies; Sputum | 1996 |
Intense photophobia caused by Arthrographis kalrae in a contact lens-wearing patient.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Contact Lenses; Cornea; Eye Infections, Fungal; Female; Humans; Keratitis; Ketoconazole; Light; Middle Aged; Mitosporic Fungi; Mycoses; Ophthalmic Solutions; Vision Disorders | 1997 |
Effect of pH and buffer system on the in-vitro activity of five antifungals against yeasts.
Topics: Amphotericin B; Antifungal Agents; Buffers; Candida; Culture Media; Fluconazole; Flucytosine; Fungi; Hydrogen-Ion Concentration; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results; Species Specificity; Spectrophotometry | 1997 |
Rapid high performance liquid chromatographic assay for antifungal agents in human sera.
Topics: Amphotericin B; Antifungal Agents; Chromatography, High Pressure Liquid; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Spectrophotometry, Ultraviolet | 1996 |
Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Biological Transport; Candida albicans; Drug Resistance, Microbial; Fluconazole; Genes, Fungal; Genes, MDR; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; RNA, Messenger | 1997 |
Invasive Aspergillus tympanomastoiditis in an immunocompetent patient.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Ketoconazole; Mastoiditis; Middle Aged; Temporal Bone; Tomography, X-Ray Computed; Tympanic Membrane | 1997 |
Outpatient therapy of HIV-associated oral and oesophageal candidosis.
Topics: AIDS-Related Opportunistic Infections; Ambulatory Care; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Esophagitis; Fluconazole; Guidelines as Topic; Humans; Itraconazole; Ketoconazole; Medical Audit; Nystatin; Retrospective Studies | 1997 |
Systemic antifungal drugs.
Topics: Amphotericin B; Anorexia; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Coccidioidomycosis; Cryptococcosis; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluconazole; Flucytosine; Gynecomastia; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Kidney Diseases; Liposomes; Male; Mixed Function Oxygenases; Mucormycosis; Nausea; Paracoccidioidomycosis; Sporotrichosis; Teratogens | 1997 |
[In vitro susceptibility to antifungal agents of Candida strains isolated from patients with various diseases of the respiratory tract].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Middle Aged; Nystatin; Respiratory Tract Infections; Species Specificity; Sputum | 1997 |
Prediction of relapse after treatment of coccidioidomycosis.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Coccidioidomycosis; Cohort Studies; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Predictive Value of Tests; Recurrence; Retrospective Studies | 1997 |
Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-t etrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Evaluation Studies as Topic; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1998 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbial; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Fluconazole; Fungemia; Humans; Incidence; Itraconazole; Ketoconazole; Male; Mitosporic Fungi; Neoplasms; Pichia; Retrospective Studies; Risk Factors; Slovakia; Treatment Outcome | 1998 |
Disseminated histoplasmosis in an 'immunocompetent' child.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Child; Histoplasma; Histoplasmosis; Humans; Immunocompetence; Itraconazole; Ketoconazole; Male; Vancomycin | 1998 |
The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
Topics: Adhesiveness; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Oral; Culture Media; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; HIV Seronegativity; Humans; Ketoconazole; Microscopy, Electron, Scanning; Mouth; Nystatin | 1998 |
Cryptococcosis in an eastern water skink.
Topics: Amphotericin B; Animals; Anti-Infective Agents; Antifungal Agents; Cryptococcosis; Enrofloxacin; Fluoroquinolones; Ketoconazole; Lizards; Quinolones | 1998 |
Blastomycosis in dogs: 115 cases (1980-1995).
Topics: Age Distribution; Amphotericin B; Animals; Antibodies, Fungal; Antifungal Agents; Blastomyces; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Fluconazole; Housing, Animal; Immunodiffusion; Itraconazole; Ketoconazole; Louisiana; Male; Radiography, Thoracic; Retrospective Studies; Seasons; Treatment Outcome | 1998 |
Aspergillus versicolor as cause of onychomycosis: report of 12 cases and susceptibility testing to antifungal drugs.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Female; Foot Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Spain; Terbinafine | 1998 |
Study of the susceptibility of yeast isolates of clinical interest to five antifungal agents using the E test.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Prototheca | 1998 |
[Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus; Econazole; Flucytosine; Ketoconazole; Miconazole; Nystatin; Saccharomyces cerevisiae; Yeasts | 1998 |
Adhesion of oral Candida albicans isolates to denture acrylic following limited exposure to antifungal agents.
Topics: Adhesiveness; Administration, Topical; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; Denture Bases; Drug Administration Schedule; Fluconazole; Flucytosine; Humans; Image Processing, Computer-Assisted; Ketoconazole; Mouth; Nystatin; Polymethyl Methacrylate; Stomatitis, Denture; Surface Properties; Time Factors | 1998 |
Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Fluconazole; Flucytosine; Hospitals, University; Humans; Itraconazole; Ketoconazole; Lebanon; Microbial Sensitivity Tests | 1998 |
Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital.
Topics: Adult; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candidiasis; Cross Infection; Fluconazole; Hospitals, University; Humans; Incidence; Intensive Care Units; Iowa; Ketoconazole; Medical Records; Postoperative Complications | 1999 |
Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Cryptococcus; Fluconazole; Flucytosine; Guidelines as Topic; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards; Yeasts | 1999 |
The postantifungal effect (PAFE) of antimycotics on oral C. albicans isolates and its impact on candidal adhesion.
Topics: Acrylic Resins; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Cell Adhesion; Denture Bases; Fluconazole; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Nystatin | 1998 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Female; Fluconazole; France; Fungemia; Hospitals, University; Humans; Infant; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Postoperative Complications; Saccharomyces cerevisiae | 1999 |
Comparative evaluation of Fungitest-, Neo-Sensitabs- and M27T-NCCLS broth microdilution methods for antifungal drug susceptibility testing of Candida species and Cryptococcus neoformans.
Topics: Amphotericin B; Antifungal Agents; Candida; Cryptococcus neoformans; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Reagent Kits, Diagnostic | 1999 |
[Determination of the in vitro antifungal susceptibility of clinically important yeasts using the Sensititre system].
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Yeasts | 1999 |
Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
Topics: Aged; Amphotericin B; Antifungal Agents; Brazil; Fatal Outcome; Female; Histoplasma; Histoplasmosis; Humans; Immunodiffusion; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Lung Diseases, Obstructive; Male; Middle Aged; Radiography, Thoracic; Recurrence; Sputum | 1999 |
Disseminated histoplasmosis in infants.
Topics: Amphotericin B; Antifungal Agents; Costa Rica; Endemic Diseases; Female; Histoplasmosis; Humans; Infant; Ketoconazole; Male; Survival Analysis | 1999 |
Evaluation of a capacitance method for direct antifungal susceptibility testing of yeasts in positive blood cultures.
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; Drug Resistance, Microbial; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Reproducibility of Results | 2000 |
Biotypes of oral Candida albicans isolated from AIDS patients and HIV-free subjects in Thailand.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Candida albicans; Candidiasis, Oral; Dose-Response Relationship, Drug; HIV Seronegativity; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Saliva | 2000 |
Effects of amphotericin B and three azole derivatives on the lipids of yeast cells of Paracoccidioides brasiliensis.
Topics: Amphotericin B; Antifungal Agents; Azoles; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Paracoccidioides; Sterols | 2000 |
Cryptococcal osteomyelitis of the spine.
Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Bone Transplantation; Child; Combined Modality Therapy; Cryptococcosis; Decompression, Surgical; Diagnosis, Differential; Female; Flucytosine; Humans; Ketoconazole; Male; Spondylitis | 1999 |
Susceptibility testing of Candida species: comparison of NCCLS microdilution method with Fungitest.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests | 2000 |
Effects of amphotericin B and ketoconazole on mouse oocyte maturation: implications on the role of meiosis-activating sterol.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Cell Differentiation; Cells, Cultured; Female; Ketoconazole; Meiosis; Mice; Oocytes; Sterols | 2000 |
Chronic paronychia, osteomyelitis, and paravertebral abscess in a child with blastomycosis.
Topics: Abscess; Amphotericin B; Antifungal Agents; Blastomycosis; Child; Chronic Disease; Humans; Ketoconazole; Male; Osteomyelitis; Paronychia; Spinal Diseases | 2000 |
Antimicrobial susceptibility testing of dematiaceous filamentous fungi: effect of medium composition at different temperatures and times of reading.
Topics: Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Flucytosine; Fungi; Hot Temperature; Humans; Ketoconazole; Multivariate Analysis; Mycoses; Reproducibility of Results; Statistics, Nonparametric; Time Factors | 1999 |
The combination of oral amphotericin B with azoles prevents the emergence of resistant Candida species in neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Bone Marrow Transplantation; Candida; Candidiasis; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Hematologic Neoplasms; Humans; Itraconazole; Ketoconazole; Neutropenia; Prospective Studies; Retrospective Studies | 2001 |
Influence of pH and concentration on the postantifungal effect and on the effects of sub-MIC concentrations of 4 antifungal agents on previously treated Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hydrogen-Ion Concentration; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2000 |
Determination of minumum inhibitory concentrations of Candida species isolated from vaginal swab specimens by using broth macrodilution and E-test.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Vagina | 2001 |
[The regulating mechanism of anti-fungicides on mouse oocyte development].
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Follicle Stimulating Hormone; In Vitro Techniques; Ketoconazole; Meiosis; Mice; Oocytes | 2000 |
In-vitro activity of five antifungal agents against uncommon clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 1999 |
Treatment for coccidioidomycosis in pregnancy?
Topics: Amphotericin B; Antifungal Agents; Coccidioidomycosis; Erythema Nodosum; Female; Fluconazole; Humans; Ketoconazole; Patient Selection; Pregnancy; Pregnancy Complications, Infectious; Risk Factors | 2001 |
Effect of inoculum form on in vitro antifungal susceptibilities of Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Spores, Fungal | 2001 |
Histoplasmosis: update 1998.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Central Nervous System Diseases; Clinical Trials as Topic; Dosage Forms; Fluconazole; Histoplasmosis; Itraconazole; Ketoconazole; Remission Induction | 1998 |
[Endemic mycotic infections].
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Diagnosis, Differential; Fluconazole; Histoplasmosis; Humans; Itraconazole; Ketoconazole; Travel | 2001 |
Heterogeneity in antifungal susceptibility of clones of Candida albicans isolated on single and sequential visits from a HIV-infected southern Chinese cohort.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Analysis of Variance; Antifungal Agents; Candida albicans; Candidiasis, Oral; China; Cohort Studies; Drug Resistance, Microbial; Ethnicity; Female; Fluconazole; Follow-Up Studies; HIV Infections; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Recurrence | 2001 |
Post-antifungal effect of polyene, azole and DNA-analogue agents against oral Candida albicans and Candida tropicalis isolates in HIV disease.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Fluconazole; Flucytosine; HIV Infections; Humans; Ketoconazole; Microbial Sensitivity Tests; Nystatin; Oropharynx; Pharyngeal Diseases; Statistics as Topic; Time Factors; Virulence | 2001 |
[In vitro antifungal susceptibility of dematiaceous filamentous fungi using the E-test].
Topics: Agar; Amphotericin B; Antifungal Agents; Colony Count, Microbial; Culture Media; Diffusion; Drug Resistance, Fungal; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi | 2001 |
No evidence of oxidant events in amphotericin B cytotoxicity versus L. infantum promastigotes.
Topics: Amphotericin B; Animals; Antifungal Agents; Antioxidants; Antiprotozoal Agents; Ascorbic Acid; Catalase; Cell Membrane; Cell Membrane Permeability; Flow Cytometry; Ketoconazole; Leishmania infantum; Leishmaniasis, Visceral; Membrane Potentials; Mycoses; Parasitic Sensitivity Tests | 2001 |
Gene amplification in amphotericin B-resistant Leishmania tarentolae.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; DNA, Circular; DNA, Protozoan; Drug Resistance; Gene Amplification; Ketoconazole; Leishmania; Mutation; Transfection | 2001 |
Post-antifungal effect and effects of sub-MIC concentrations on previously treated Candida spp.: influence of exposure time and concentration.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Time Factors | 2002 |
Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Colorimetry; Coloring Agents; Dermatomycoses; Drug Resistance, Fungal; Epidermophyton; Fluconazole; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Microsporum; Oxazines; Sensitivity and Specificity; Trichophyton; Xanthenes | 2002 |
[Identification and antifungal susceptibility of Candida spp isolated from invasive mycoses. Influence of growth inhibition percentage to determine minimal inhibitory concentration].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child; Fluconazole; Growth Inhibitors; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2002 |
Mathematical modelling of antifungal action.
Topics: Amphotericin B; Antifungal Agents; Euphorbia; Ketoconazole; Latex; Microbial Sensitivity Tests; Models, Biological; Yeasts | 2002 |
[Conjunctival infection due to penicillium SP].
Topics: Aged; Amphotericin B; Antifungal Agents; Conjunctivitis; Eye Infections, Fungal; Humans; Ketoconazole; Male; Mycoses; Penicillium; Treatment Outcome | 2003 |
Prevalence and antifungal susceptibilities of yeast isolates during one year at a university hospital in Turkey.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple, Fungal; Fluconazole; Hospitals, University; Humans; Ketoconazole; Microbial Sensitivity Tests; Prevalence; Turkey | 2002 |
Pulmonary candidiasis caused by Candida albicans in a Greek tortoise (Testudo graeca) and treatment with intrapulmonary amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Infusions, Intralesional; Ketoconazole; Liver; Lung Diseases, Fungal; Treatment Outcome; Turtles | 2001 |
Anti-Aspergillus activities of plant essential oils and their combination effects with ketoconazole or amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus flavus; Aspergillus niger; Drug Synergism; Gas Chromatography-Mass Spectrometry; Ketoconazole; Microbial Sensitivity Tests; Oils, Volatile; Plant Oils | 2003 |
[Nosocomial urinary infection due to Trichosporon asahii. First two cases in Chile].
Topics: Amphotericin B; Antifungal Agents; Chile; Communicable Diseases, Emerging; Cross Infection; Drug Resistance, Fungal; Fatal Outcome; Fluconazole; Humans; Immunocompromised Host; Intensive Care Units; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Multiple Myeloma; Mycoses; Opportunistic Infections; Parkinson Disease; Postoperative Complications; Trichosporon; Urinary Catheterization; Urinary Tract Infections; Ventriculoperitoneal Shunt | 2003 |
Modulatory effect of cAMP on fungal ergosterol level and inhibitory activity of azole drugs.
Topics: Amphotericin B; Antifungal Agents; Atropine; Bucladesine; Candida albicans; Chromatography, Gas; Cryptococcus neoformans; Cyclic AMP; Drug Synergism; Ergosterol; Fluconazole; Ketoconazole; Microbial Sensitivity Tests; Phosphodiesterase Inhibitors | 2003 |
[Madura foot (mycetoma)].
Topics: Adult; Amphotericin B; Amputation, Surgical; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Doxycycline; Humans; Ketoconazole; Male; Mycetoma; Sulfanilamides; Time Factors; Wound Healing | 2003 |
Activities of therapeutic agents against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.
Topics: Acetamides; Adolescent; Amebiasis; Amebicides; Amphotericin B; Animals; Central Nervous System Protozoal Infections; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Ketoconazole; Linezolid; Liposomes; Male; Mice; Minocycline; Naegleria fowleri; Oxazolidinones; Trifluoperazine; Virginiamycin | 2003 |
Fungal infection of sutureless self-sealing incision for cataract surgery.
Topics: Aged; Aged, 80 and over; Amphotericin B; Aspergillosis; Candidiasis; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Humans; Ketoconazole; Male; Minimally Invasive Surgical Procedures; Natamycin; Phacoemulsification; Retrospective Studies; Scleritis; Surgical Wound Infection; Suture Techniques | 2003 |
Experimental evaluation of antifungal and antiseptic agents against Rhodotorula spp.
Topics: Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Rhodotorula | 2003 |
Effect of antifungal drugs on pathogenic Naegleria spp isolated from natural water sources.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Ketoconazole; Naegleria; Water Microbiology | 2003 |
Prevalence of Candida dubliniensis among germ tube-positive yeasts recovered from the respiratory specimens in HIV-negative patients.
Topics: Adult; Aged; Amphotericin B; Candida; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Respiratory System; Saudi Arabia; Serotyping | 2004 |
Susceptibility of sequential Fonsecaea pedrosoi isolates from chromoblastomycosis patients to antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Chromoblastomycosis; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine | 2004 |
Antifungal susceptibility of 50 Candida isolates from invasive mycoses in Chile.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Chile; Critical Care; Drug Resistance, Fungal; Fluconazole; Humans; Inpatients; Intensive Care Units; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2004 |
In vitro susceptibility of Candida species isolated from cancer patients to some antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Disease Susceptibility; Fluconazole; Flucytosine; Humans; Ketoconazole; Microbial Sensitivity Tests; Mycoses; Neoplasms; Oropharynx | 2004 |
Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
Topics: Amphotericin B; Antifungal Agents; Candida; Colorimetry; Itraconazole; Ketoconazole; Laboratories; Microbial Sensitivity Tests; Quality Assurance, Health Care; Reference Standards | 2004 |
Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
Topics: Agastache; Allylbenzene Derivatives; Amphotericin B; Anisoles; Antifungal Agents; Candida; Drug Therapy, Combination; Humans; Ketoconazole; Microbial Sensitivity Tests; Phytotherapy; Plant Oils | 2004 |
Clinicopathologic features of an unusual outbreak of cryptococcosis in dogs, cats, ferrets, and a bird: 38 cases (January to July 2003).
Topics: Amphotericin B; Animals; Antifungal Agents; Bird Diseases; British Columbia; Cat Diseases; Cats; Cockatoos; Colony Count, Microbial; Cryptosporidiosis; Disease Outbreaks; Dog Diseases; Dogs; Female; Ferrets; Ketoconazole; Male; Microbial Sensitivity Tests; Retrospective Studies; Treatment Outcome | 2004 |
Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Proliferation; Drug Evaluation, Preclinical; Fibroblasts; Humans; In Vitro Techniques; Indoles; Ketoconazole; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship | 2004 |
Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Caspofungin; Echinocandins; Flucytosine; Fungal Proteins; Gene Expression Profiling; Gene Expression Regulation, Bacterial; Genome, Fungal; Humans; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Oligonucleotide Array Sequence Analysis; Peptides, Cyclic; Polyenes; Pyrimidines | 2005 |
Slime production and proteinase activity of Candida species isolated from blood samples and the comparison of these activities with minimum inhibitory concentration values of antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Peptide Hydrolases | 2005 |
Clinical results of topical fluconazole for the treatment of filamentous fungal keratitis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Drug Therapy, Combination; Eye Infections, Fungal; Female; Fluconazole; Fungi; Humans; Keratitis; Ketoconazole; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Treatment Outcome | 2006 |
DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; DNA Fingerprinting; DNA, Fungal; Drug Resistance, Fungal; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Soil Microbiology; Spain; Triazoles; Voriconazole | 2005 |
In vitro susceptibility of oral Candida to seven antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole | 2005 |
Clinical evolution of paracoccidioidomycosis in 38 children and teenagers.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Female; Humans; Ketoconazole; Male; Paracoccidioides; Paracoccidioidomycosis; Prospective Studies; Retrospective Studies; Sulfonamides; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
[The effect of propyl gallate on the activity of various antifungal drugs against filamentous fungi in vitro].
Topics: Amphotericin B; Antifungal Agents; Antioxidants; Aspergillus flavus; Aspergillus fumigatus; Benzylamines; Drug Synergism; Fungi; Fusarium; In Vitro Techniques; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propyl Gallate; Terbinafine | 2006 |
In vitro susceptibilities of Malaysian clinical isolates of Cryptococcus neoformans var. grubii and Cryptococcus gattii to five antifungal drugs.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Transcriptional profiles of the response to ketoconazole and amphotericin B in Trichophyton rubrum.
Topics: Amphotericin B; Antifungal Agents; Gene Expression Profiling; Gene Expression Regulation, Fungal; Genes, Fungal; Ketoconazole; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; Trichophyton | 2007 |
In-vitro susceptibility testing by agar dilution method to determine the minimum inhibitory concentrations of amphotericin B, fluconazole and ketoconazole against ocular fungal isolates.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Candida; Drug Resistance, Fungal; Eye Diseases; Fluconazole; Keratitis; Ketoconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Mycoses | 2006 |
Eumycetoma presenting as a cerebellopontine angle mass lesion.
Topics: Adult; Amphotericin B; Antifungal Agents; Brain Edema; Brain Stem; Cerebellar Diseases; Cerebellopontine Angle; Decompression, Surgical; Drug Therapy, Combination; Female; Humans; Hydrocephalus; Ketoconazole; Magnetic Resonance Imaging; Mycetoma; Otitis Media with Effusion; Scedosporium; Tomography, X-Ray Computed; Ventriculoperitoneal Shunt | 2007 |
Candida interface keratitis after deep anterior lamellar keratoplasty: clinical, microbiologic, histopathologic, and confocal microscopic reports.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cornea; Corneal Transplantation; Drug Therapy, Combination; Eye Infections, Fungal; Humans; Keratitis; Keratoconus; Keratoplasty, Penetrating; Ketoconazole; Male; Microscopy, Confocal; Natamycin; Postoperative Complications | 2007 |
Antifungal canthin-6-one series accumulate in lipid droplets and affect fatty acid metabolism in Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Carbolines; Drug Synergism; Fatty Acid Desaturases; Fatty Acids; Indole Alkaloids; Indoles; Ketoconazole; Microbial Sensitivity Tests; Naphthyridines; Saccharomyces cerevisiae | 2008 |
Activity of caspofungin and voriconazole against clinical isolates of Candida and other medically important yeasts by the CLSI M-44A disk diffusion method with Neo-Sensitabs tablets.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus; Disk Diffusion Antimicrobial Tests; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Pyrimidines; Rhodotorula; Triazoles; Trichosporon; Voriconazole | 2008 |
Chemosensitization prevents tolerance of Aspergillus fumigatus to antimycotic drugs.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Benzaldehydes; Catechols; Cell Membrane; Cell Wall; Drug Resistance, Fungal; Fluconazole; Gene Deletion; Humans; Ketoconazole; Microbial Sensitivity Tests; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Sorbitol; Thymol | 2008 |
Antifungal activities of natural and synthetic iron chelators alone and in combination with azole and polyene antibiotics against Aspergillus fumigatus.
Topics: Amphotericin B; Antifungal Agents; Aspergillus fumigatus; Ciclopirox; Deferiprone; Drug Combinations; Fluconazole; Iron Chelating Agents; Ketoconazole; Microbial Sensitivity Tests; Pyridones | 2009 |
Growth inhibitory action of ebselen on fluconazole-resistant Candida albicans: role of the plasma membrane H+-ATPase.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida albicans; Cyclooxygenase Inhibitors; Cysteine; Drug Resistance, Fungal; Fluconazole; Isoindoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Organoselenium Compounds; Proton-Translocating ATPases; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins | 2009 |
In vitro synergistic effects of antituberculous drugs plus antifungals against Coccidioides posadasii.
Topics: Amphotericin B; Antifungal Agents; Antitubercular Agents; Caspofungin; Coccidioides; Coccidioidomycosis; Drug Synergism; Echinocandins; Ethambutol; Fluconazole; Humans; Isoniazid; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrazinamide; Pyrimidines; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
Topics: Amphotericin B; Antifungal Agents; Candida; Colony Count, Microbial; Curcuma; Drug Synergism; Ketoconazole; Microbial Sensitivity Tests; Microbial Viability; Molecular Structure; Phenols; Time Factors | 2009 |
The post-antifungal effect (PAFE) of amphotericin B, nystatin, ketoconazole and 5-fluorocytosine and its impact on the colonization traits of Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Biomass; Candida glabrata; Candidiasis; Cell Adhesion; Cell Wall; Epithelial Cells; Flucytosine; Humans; Hydrophobic and Hydrophilic Interactions; Ketoconazole; Nephelometry and Turbidimetry; Nystatin | 2010 |
Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents.
Topics: Adaptation, Physiological; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Electrophoresis, Gel, Two-Dimensional; Ergosterol; Humans; Ketoconazole; Lipopeptides; Oxidative Stress; Proteome; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Water-Electrolyte Balance | 2010 |
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.
Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Child; Female; Humans; Ketoconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Middle Aged; Phosphorylcholine; Species Specificity | 2011 |
[Management of invasive fungal infections in children].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child; Echinocandins; Humans; Ketoconazole; Mycoses; Prognosis; Treatment Outcome | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Apoptosis; ATP-Binding Cassette Transporters; Biological Transport, Active; Candida albicans; Drug Resistance, Multiple, Fungal; Drug Synergism; Farnesol; Fluconazole; Fungal Proteins; Ketoconazole; Kinetics; Membrane Transport Proteins; Miconazole; Microbial Sensitivity Tests; Quorum Sensing; Reactive Oxygen Species; Rhodamines; Saccharomyces cerevisiae | 2011 |
Evaluation of saliva flow rates, Candida colonization and susceptibility of Candida strains after head and neck radiation.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Colony Count, Microbial; Dental Caries; Drug Resistance, Fungal; Female; Fluconazole; Head and Neck Neoplasms; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mouth; Pyrimidines; Radiation Injuries; Saliva; Salivary Glands; Secretory Rate; Triazoles; Voriconazole; Xerostomia | 2012 |
In vitro and in vivo trypanocidal synergistic activity of N-butyl-1-(4-dimethylamino)phenyl-1,2,3,4-tetrahydro-β-carboline-3-carboxamide associated with benznidazole.
Topics: Amphotericin B; Animals; Body Weight; Carbolines; Cell Count; Cell Line; Chagas Disease; Drug Combinations; Drug Resistance; Drug Synergism; Haplorhini; Heart; Humans; Ketoconazole; Life Cycle Stages; Male; Mice; Mice, Inbred BALB C; Nitroimidazoles; Survival Rate; Trypanocidal Agents; Trypanosoma cruzi | 2012 |
Comparison of the effect of non-antifungal and antifungal agents on Candida isolates from the gastrointestinal tract.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Amphotericin B; Antifungal Agents; Antipsychotic Agents; Candida; Candida tropicalis; Colony Count, Microbial; Drug Resistance, Microbial; Gastrointestinal Tract; Humans; Ketoconazole; Lansoprazole; Propranolol; Trifluoperazine | 2012 |
Fluconazole exposure rather than clonal spreading is correlated with the emergence of Candida glabrata with cross-resistance to triazole antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Prototheca wickerhamii as a cause of neuroinfection in a child with congenital hydrocephalus. First case of human protothecosis in Poland.
Topics: Amphotericin B; Antifungal Agents; DNA, Plant; Fluconazole; Head; Humans; Hydrocephalus; Infant; Ketoconazole; Male; Meningoencephalitis; Microscopy, Electron; Molecular Sequence Data; Poland; Prototheca; Sequence Analysis, DNA; Tomography, X-Ray Computed; Treatment Outcome; Ventriculoperitoneal Shunt | 2012 |
Rhino-orbito-cerebral mucormycosis: five cases.
Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Antifungal Agents; Biopsy; Cavernous Sinus Thrombosis; Combined Modality Therapy; Cranial Nerve Diseases; Debridement; Diabetes Complications; Diabetic Ketoacidosis; Disease Susceptibility; Drug Substitution; Encephalitis; Exophthalmos; Female; Humans; Ketoconazole; Male; Middle Aged; Mucorales; Mucormycosis; Orbital Cellulitis; Retrospective Studies; Rhinitis; Sinusitis; Tomography, X-Ray Computed | 2012 |
In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Topics: Amphotericin B; Antifungal Agents; Arthrodermataceae; Drug Resistance, Fungal; Epidermophyton; Griseofulvin; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton; Turkey | 2013 |
Alternaria keratitis and hypopyon after clear-cornea phacoemulsification.
Topics: Abscess; Administration, Oral; Aged; Alternaria; Alternariosis; Amphotericin B; Antifungal Agents; Cornea; Corneal Ulcer; Eye Infections, Fungal; Female; Humans; Injections, Intraocular; Ketoconazole; Lens Implantation, Intraocular; Phacoemulsification; Visual Acuity | 2014 |
Clinical, morphological, and molecular characterization of Penicillium canis sp. nov., isolated from a dog with osteomyelitis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cluster Analysis; DNA, Fungal; DNA, Ribosomal Spacer; Dog Diseases; Dogs; Female; Fungal Proteins; Histocytochemistry; Ketoconazole; Molecular Sequence Data; Naphthalenes; Osteomyelitis; Penicillium; Phylogeny; Radiography, Abdominal; Sequence Analysis, DNA; Terbinafine; Treatment Outcome | 2014 |
Post-antifungal effect and adhesion to buccal epithelial cells of oral Candida dubliniensis isolates subsequent to limited exposure to amphotericin B, ketoconazole and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Cells, Cultured; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Mycology; Nephelometry and Turbidimetry | 2015 |
Impact of brief and sequential exposure to nystatin, amphotericin B, ketoconazole, and fluconazole in modulating adhesion traits of oral Candida dubliniensis isolates.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Epithelial Cells; Fluconazole; Humans; Ketoconazole; Microbial Sensitivity Tests; Mouth Mucosa; Nystatin | 2016 |
Synthesis, morphology and antifungal activity of nano-particulated amphotericin-B, ketoconazole and thymoquinone against Candida albicans yeasts and Candida biofilm.
Topics: Amphotericin B; Antifungal Agents; Benzoquinones; Biofilms; Candida albicans; Ketoconazole; Microbial Sensitivity Tests; Nanoparticles; Particle Size; Species Specificity; Yeasts | 2015 |
Antifungal susceptibility and phenotypic characterization of oral isolates of a black fungus from a nasopharyngeal carcinoma patient under radiotherapy.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Carcinoma; Caspofungin; Chemoradiotherapy; Chemotherapy, Adjuvant; Drug Resistance, Fungal; Echinocandins; Exophiala; Fluconazole; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Lipopeptides; Male; Middle Aged; Mouth Diseases; Nasopharyngeal Neoplasms; Neoplasm Recurrence, Local; Opportunistic Infections; Phaeohyphomycosis; Radiotherapy, Intensity-Modulated; Voriconazole | 2015 |
Impact of short-term exposure of antifungal agents on hemolysin activity of oral Candida dubliniensis isolates from Kuwait and Sri Lanka.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Chlorhexidine; Echinocandins; Fluconazole; Hemolysin Proteins; Humans; Ketoconazole; Kuwait; Lipopeptides; Microbial Sensitivity Tests; Nystatin; Sri Lanka; Time Factors | 2016 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
The anti-candidal activity of Satureja khuzistanica ethanol extract against clinical isolates of C. albicans.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Clotrimazole; Diabetes Complications; Drug Interactions; Female; Humans; Ketoconazole; Male; Microbial Sensitivity Tests; Plant Components, Aerial; Plant Extracts; Satureja; Vagina | 2016 |
Molecular typing of environmental Cryptococcus neoformans/C. gattii species complex isolates from Manaus, Amazonas, Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Birds; Brazil; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; Disease Reservoirs; Environmental Microbiology; Feces; Fluconazole; Humans; Itraconazole; Ketoconazole; Molecular Typing; Mycological Typing Techniques; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Trees | 2016 |
Onychomycosis in diabetic patients in Fako Division of Cameroon: prevalence, causative agents, associated factors and antifungal sensitivity patterns.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cameroon; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Resistance, Fungal; Female; Humans; Ketoconazole; Male; Miconazole; Microbial Sensitivity Tests; Middle Aged; Nails; Onychomycosis; Prevalence; Trichophyton | 2016 |
Comparison of two in vitro antifungal sensitivity tests and monitoring during therapy of Sporothrix schenckii sensu stricto in Malaysian cats.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; In Vitro Techniques; Itraconazole; Ketoconazole; Malaysia; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2017 |
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cats; Drug Resistance, Fungal; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Sporothrix; Terbinafine; Triazoles | 2017 |
Candidiasis: Prevalence and resistance profiling in a tertiary care hospital of Pakistan.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Ketoconazole; Kidney Failure, Chronic; Kidney Transplantation; Microbial Sensitivity Tests; Pakistan; Prevalence; Prospective Studies; Tertiary Care Centers; Voriconazole | 2017 |
Silver nanoparticles from Pilimelia columellifera subsp. pallida SL19 strain demonstrated antifungal activity against fungi causing superficial mycoses.
Topics: 3T3 Cells; Actinobacteria; Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Fungi; HeLa Cells; Humans; Ketoconazole; Metal Nanoparticles; Mice; Microbial Sensitivity Tests; Mycoses; Silver | 2017 |
Auricular Swelling After Mild Trauma.
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Biopsy; Diagnosis, Differential; Drug Therapy, Combination; Ear Diseases; Female; Humans; Ketoconazole; Leishmaniasis, Cutaneous; Middle Aged; Plant Extracts; Wounds, Nonpenetrating | 2018 |
Antifungal susceptibility of yeasts isolated from anthropogenic watershed.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fresh Water; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reference Values; Sequence Analysis, DNA; Voriconazole; Yeasts | 2019 |
Synthesis and Antifungal Potential of Some Novel Benzimidazole-1,3,4-Oxadiazole Compounds.
Topics: Amphotericin B; Animals; Antifungal Agents; Benzimidazoles; Candida albicans; Cell Survival; Drug Design; Ketoconazole; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; NIH 3T3 Cells; Oxadiazoles; Protein Binding; Structure-Activity Relationship | 2019 |
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Canine sporotrichosis: polyphasic taxonomy and antifungal susceptibility profiles of Sporothrix species in an endemic area in Brazil.
Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Dog Diseases; Dogs; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Terbinafine | 2021 |
Molecular diagnosis and therapy for cutaneous leishmaniasis of a returned traveler from Mexico.
Topics: Adult; Amphotericin B; DNA, Protozoan; Humans; Ketoconazole; Leishmania mexicana; Leishmaniasis, Cutaneous; Male; Travel-Related Illness; Treatment Outcome | 2021 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
Malassezia species: the need to establish epidemiological cutoff values.
Topics: Amphotericin B; Animals; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Voriconazole | 2022 |
Feline sporotrichosis caused by Sporothrix schenckii sensu stricto in Southern Thailand: phenotypic characterization, molecular identification, and antifungal susceptibility.
Topics: Amphotericin B; Animals; Antifungal Agents; Calmodulin; Cat Diseases; Cats; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Phylogeny; Sporothrix; Sporotrichosis; Thailand; Tubulin | 2022 |